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ABSTRACT
Essential oils (EOs) are plant-derived products that have been long exploited for their
antimicrobial activities in medicine, agriculture, and food preservation. EOs represent a
promising alternative to conventional antibiotics due to the broad-range antimicrobial
activity, low toxicity to human commensal bacteria, and the capacity to kill
microorganisms without promoting resistance. Despite the progress in the understanding
of the biological activity of EOs, many aspects of their mode of action remain
inconclusive. The overarching aim of this work was to address these gaps by studying
molecular interactions between antimicrobial plant aldehydes and the opportunistic
human pathogen Pseudomonas aeruginosa. We initiated my project by identifying
synergistically acting combinations of phytoaldehydes and using thiol-ene chemistry to
incorporate the synergistic pairs into pro-antimicrobial polymers. Such polymers released
phytoaldehydes upon a change in pH and humidity and controlled growth of P.
aeruginosa. Next, we used a combination of transposon mutagenesis, and RNA-seq to
elucidate cellular pathways targeted by p-anisaldehyde (an EO constituent from star
anise) and the polyphenol from green tea epigallocatechin gallate (EGCG). The results of
these experiments identified key microbial genes and associated pathways involved in
response to antimicrobial plant-derived phenylpropanoids and revealed molecular
mechanisms governing the synergistic effects of individual constituents within essential
oils. Finally, we broadened the antimicrobial potential of the thiol-ene polymer platform
by incorporating a combination of p-anisaldehyde and furaneol, which is a natural plantderived inhibitor of quorum sensing. The treatment with furaneol/p-anisaldehydecontaining polymeric discs strongly repressed the production of pyocyanin, reduced the
ii

exoprotease activity, and effectively eradicated established P. aeruginosa biofilms. Our
results will facilitate the development of polymeric systems capable of dual
phytochemical delivery and controlling microbial growth without promoting antibiotic
resistance. Such materials enable the high loading, efficient encapsulation, and sustained
release of hydrophobic and volatile phytochemicals and could be used as antimicrobial
wound dressings, sprays, surface coatings, and packaging materials.
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CHAPTER I - INTRODUCTION
1.1 Infectious diseases and antibiotic resistance
Pathogenic microorganisms are a continuous threat to humans regardless of age,
sex, ethnic background, and socioeconomic status. Infectious diseases represent the 3rd
leading cause of death in the US and infect almost a billion people across the globe
causing 15 million deaths annually.12 These diseases also impose a significant financial
burden on affected people and the society at large, and their incidence is exacerbated by
the rise in the number of people with organ transplants, cancer, and genetic diseases, such
as cystic fibrosis.3 Although most infections can be readily treated with antibiotics, the
global spread of resistance driven by the misuse and overuse of antibiotics in medicine
and agriculture threatens the sustainability of public health.4,5 The antibiotic-resistant
pathogens persist longer, inflict more damage to the host via the tissue inflammation,
sepsis, and, in some cases, death.1 The World Health Organization (WHO) estimates that
antibiotic-resistant infections cause up to 700,000 deaths globally.6 The United States
alone spends an extra $35 billion annually on health care associated with the rise in
antibiotic resistance.7
The WHO recognizes Acinetobacter baumannii, Pseudomonas aeruginosa, and
carbapenem-resistant Enterobacteriaceae, such as Klebsiella, Escherichia coli, Serratia,
and Proteus as the greatest threat to hospitals, nursing facilities, and patients on
ventilators or with blood catheters.8 Other important multidrug (MDR) species include
the vancomycin-resistant Enterococcus faecium, methicillin- and vancomycin-resistant
Staphylococcus aureus, clarithromycin-resistant Helicobacter pylori, and
fluoroquinolone-resistant Campylobacter, Salmonella, and Neisseria gonorrhoeae. Many
1

of these MDR pathogens can cause severe bloodstream infections and pneumonia and are
associated with increased morbidity, extended hospital stays, and mortality.9 The WHO
also warns about a lack of new antibiotics to counteract the growing threat of
antimicrobial resistance. The agency indicated that of the 51 antibiotics that are currently
in clinical development, only eight are sufficiently novel to add value to the existing
treatments of antibiotic-resistant pathogens.10 If this trend continues, an estimated ten
million additional deaths will occur because of bacterial infections by the year 2050.6
1.2 Plant essential oils as a rich source of natural antimicrobial compounds
The global rise in the multidrug resistance has led to a renewed interest in the use
of alternative approaches for controlling microbial pathogens, such as phage therapy and
the use of essential oils, whose antimicrobial properties have been recognized in
traditional medicine for centuries.11 Essential oils (EOs) are aromatic and volatile liquids
or solids that are extracted from roots, flowers, leaves, and fruits of certain plants. 11–14
Currently, over 3,000 different EOs are known, and about 300 are being produced
commercially for culinary purposes or as ingredients of perfumes and cosmetics.12,15,16
EOs have also been utilized since ancient times due to their analgesic, antioxidant,
sedative, anti-inflammatory, spasmolytic and local anesthetic properties.17 Finally,
essential oils represent one of the oldest known groups of antiseptics due to the presence
of numerous metabolites with broad-range antimicrobial properties.6,13,14,18 Essential oils
vary in composition depending on the plant species, growing season, the method of
extraction, and physiological state of the plant.6,11,13–15,17–20 Many plants secrete essential
oils to defend themselves against invading pathogens and, as a consequence, many EOderived alcohols, aldehydes, terpenes, ethers, ketones, and phenols have been shown to
2

have broad range antibacterial, antifungal, antiviral, antiulcer, anthelmintic, and
antioxidant properties.13,14,21 The capacity to kill a wide variety of microorganisms
without promoting resistance, and approval by the FDA as generally recognized as safe
(GRAS) substances makes EOs an attractive alternative to conventional antibiotics.11,13,19

Figure 1.1 Chemical structures of selected constituents of essential oils.
Adapted from Hyldgaard et al., 2012
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Plant essential oils contain numerous terpenes, terpenoids, phenylpropanoids, and
phenolics, many of which are active against bacteria and fungi (Figure 1.1).14 My work
focused on p-anisaldehyde (a biologically active EO constituent from star anise), and
structurally related cyanobenzaldehyde (present in the medicinal plant Saussurea
lappa),22 p-chlorobenzaldehyde, and bromobenzaldehyde (Figure 1.2). These compounds
are also naturally present in alcoholic beverages, dairy products, meat, poultry, fruits,
vegetables, and spices.

Figure 1.2 Chemical structures of selected benzaldehydes used in this study.
p-Anisaldehyde, along with better-studied cinnamaldehyde and vanillin, belong to
a group of plant metabolites known as phenylpropanoids that are named after the sixcarbon aromatic phenyl group and three-carbon propene tail produced in the first step of
biosynthesis.14,17 The antimicrobial activity of phenylpropenes depends on the number of
substituents on their aromatic ring and is further modulated by experimental conditions
and physiology of the target microorganism.14 The activity of phenylpropanoids is not
attributable to a unique mechanism but, is instead a cascade of reactions involving the
entire microbial cell.17 Three different modes of actions (MoAs) have been suggested to
explain the antimicrobial activity of cinnamaldehyde. At low concentrations, this
metabolite interferes with bacterial cell division by blocking the GTP-dependent
4

polymerization activity of FtsZ protein.23 At higher levels, it disrupts cell membranes and
acts as an ATPase inhibitor.24,25 It is currently unclear exactly how cinnamaldehyde
disrupts membranes since this compound kills some bacteria by disintegrating the cell
envelope, while other species may survive due to the increase in saturated fatty acids in
the membrane lipid profile.26 The mode of action of vanillin is thought to involve the
perturbation of membranes and several other intracellular targets.14 The antibacterial and
antifungal activity of p-anisaldehyde and structurally-related compounds is well
documented, but their mechanism of action remains poorly understood.27,28
1.3 Pseudomonas aeruginosa as a model multidrug-resistant opportunistic pathogen
P. aeruginosa is a ubiquitous gram-negative microorganism that serves as an
important model for opportunistic infections and biofilm research. This bacterium is
commonly found in soil, water, or plants, but can readily infect immunocompromised
individuals causing septicemia, wound, and urinary tract infections.5,29 It also causes
pneumonia and predominantly responsible for the increased morbidity and mortality of
cystic fibrosis patients.29,30 Over the past several decades, this organism evolved from
being primarily a burn wound pathogen into a major threat of nosocomial infections.6,9 P.
aeruginosa is now resistant to multiple classes of antibiotics and belongs to a class of
pathogens with the increased virulence, persistence and transmissibility known as the
ESKAPE group (also encompasses Enterococcus faecium, S. aureus, Klebsiella
pneumoniae, A. baumannii, and Enterobacter species) 5,7,9. The Centers for Disease
Control report that in the US P. aeruginosa is responsible for 8% of all hospital-acquired
infections and over 400 deaths per year, which are often caused by multidrug-resistant
variants of the pathogen. These MDR strains of P. aeruginosa are insensitive to nearly all
5

the available β-lactams and aminoglycosides and thus, are classified by the CDC as a
serious threat that requires close monitoring and prevention activities.5 Once acquired, P.
aeruginosa is particularly difficult to treat due to its capacity to form thick biofilms
which provide additional protection from the environmental stress, immune response, and
antimicrobial compounds.
1.4 Cell signaling and RND efflux pumps are potential drug targets to combat P.
aeruginosa infections
P. aeruginosa secretes an extensive array of virulence factors (multiple exotoxins,
rhamnolipids, cyanide, pyocyanin), and their production, as well as the formation of
biofilms and surface motility, are coordinately regulated via quorum-sensing (QS).31,32 P.
aeruginosa has two hierarchically organized QS circuits (Las and Rhl) that rely on the
production, detection, and response to N-3-oxo-dodecanoyl-homoserine lactone (3-oxoC12-HSL) and N-butanoyl-homoserine lactone (C4-HSL). A third QS system (Pqs)
regulates the acquisition of iron, cytotoxicity, and secretion of outer membrane vesicles
in response to 2-heptyl-3-hydroxy-4-quinolone.33 Collectively these quorum sensing
signals interact with transcriptional regulators in a concentration-dependent way, thus
modulating the expression of pathogenicity related traits and formation of persistent
biofilms.32,34 Human cells lack the acyl-homoserine lactone- and quinolone-based
regulation, which makes microbial QS components an attractive target for the
development of new antimicrobials.32
Several strategies of “quorum quenching” were suggested in P. aeruginosa,
including the inhibition of synthesis,35 sequestration,36 and degradation37 of acyl
homoserine lactones (AHLs). However, the most promising approach involves the use of
6

antagonistic compounds that compete with AHLs for target receptors. Different classes of
synthetic and natural AHL analogs were described, many of which were discovered in
plants extract.38 Some examples of plant-derived QS inhibitors include the polyphenolic
compounds baicalin from the roots of Scutellaria baicalensis39 and epigallocatechin from
green tea, 40 bergamottin from grapefruit juice,41 allicin and ajoene from garlic.42 A group
of potent AHL mimics known as halogenated furanones was first discovered in the red
alga Delisea pulchra, which produces the brominated metabolite (5Z)-4-bromo-5(bromomethylene)3-butyryl-2(5H)-furanone.43

Figure 1.3 Chemical structures of furaneol and epigallocatechin gallate (EGCG).
Although natural halogenated furanones and their synthetic derivatives effectively
inhibit biofilms in P. aeruginosa and other gram-positive and gram-negative pathogens,
the high toxicity of these compounds limits their potential use.38 In contrast, furaneol
(Figure 1.3), a furanone metabolite from strawberries and other fruits, is safe to humans
and used as a flavoring agent in the food industry.44 Recent studies with P. aeruginosa
also demonstrated that furaneol inhibits the synthesis of virulence factors that are
regulated by QS.31 Because of these attractive properties, part of my work involved
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combining furaneol with p-anisaldehyde to produce antimicrobial polymers capable of
eradicating P. aeruginosa biofilms.
The ability to rapidly expel a broad range of antimicrobials out of the cell
represents a vital component of the intrinsic and acquired antibiotic resistance in P.
aeruginosa.45 This organism has 12 different efflux pumps of the resistance-nodulationcell division (RND) superfamily, some of which (e.g., MexAB-OprM) are constitutively
expressed in wild-type strains and provide the intrinsic resistance to several classes of
antibiotics, disinfectants, detergents, dyes, amphiphilic molecules, and QS signals.46 In
contrast, other RND pumps (e.g., MexXY-OprM, MexCD-OprJ, MexEF-OprN) are
tightly regulated in wild type strains but can be de-repressed via regulatory mutations
resulting in the stable acquired resistance and MDR phenotypes in clinical isolates.
Because of the crucial importance of efflux pump transporters for the active drug efflux
in many gram-positive and gram-negative bacteria, recent efforts are focused on the
development of specific efflux pump inhibitors (EPIs).47 In theory, such compounds can
render obsolete antibiotics effective again and open up extensive opportunities for
adjuvant therapy. Despite significant efforts, the identification of chemicals that can
bypass efflux pump effects without disrupting the proton motive force continues to be a
challenge.48 Several active synthetic inhibitors proved to be too toxic for clinical
applications prompting researchers to screen plant extracts for natural EPIs. The results
of these ongoing studies appear to be promising and confirm that plants contain various
EPIs, especially for pumps of Gram-positive species.49 In my project, I used one of these
compounds, epigallocatechin gallate (EGCG) (Figure 1.3), which has chemical properties
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suitable for the incorporation into PANDAs and has been shown to inhibit efflux pumps
in S. aureus and interfere with QS and biofilm formation in P. aeruginosa.50,51
1.5 Research purpose, significance, and broader impacts
Despite the promising antimicrobial potential, the broader implementation of EOs
and their constituents is hampered by several technical challenges. In particular, poor
water solubility significantly limits the bioavailability and lowers biological and
antimicrobial activity of these compounds, whereas volatility is problematic for achieving
sustained release and controlled delivery. Recent work in the area of polyactive materials
offers a viable solution to these challenges. “Polyactives” refer to polymeric prodrugs
that undergo partial or complete degradation to release active therapeutic agents (e.g.,
anti-inflammatory, antioxidant, antibiotic).52 The collaborative research by the Mavrodi
group and Dr. Derek Patton from the USM School of Polymers and High Performing
Materials demonstrated that polymer-based delivery systems could successfully
circumvent the aforementioned technical issues and achieve high loading, highly efficient
“encapsulation,” solvent-free processing, and rational design of phytochemical release
profiles.53 The collaborators incorporated antimicrobial plant-derived aldehydes into
polymer compounds called PANDAs (Pro-Antimicrobial Networks via Degradable
Acetals) (Figure 1.4). These materials were designed to release incorporated aldehydes
upon exposure to conditions conducive to acetal degradation (e.g., change in humidity
and pH), and demonstrated good antimicrobial activity against both bacterial and fungal
pathogens, including P. aeruginosa PAO1, Salmonella typhimurium ATCC 6539, E. coli
ATCC 43895 (serotype O157:H7), and Histoplasma capsulatum G217B, and exhibited a
low cytotoxic effect on KB (HeLa) cells. 54
9

Figure 1.4 Synthesis of Pro-Antimicrobial Networks via Degradable Acetals (PANDAs).
The PANDAs polymers are designed to kill microorganisms via partial degradation and release of plant-derived antimicrobial
aldehydes, such as p-anisaldehyde (adapted from Amato et al., 2016).

Based on the results of previous studies, I hypothesized that the antimicrobial
efficacy of PANDAs could be further improved by understanding their cellular targets
and developing polymeric systems capable of simultaneous delivery of synergistically
interacting combinations of antimicrobial phytochemicals. Accordingly, in the first part
of my project, I screened combinations of phytoaldehydes for synergistic antimicrobial
activity against P. aeruginosa by determining their fractional inhibitory
concentrations. I then collaborated with the Patton research group on the synthesis of the
dual-release PANDA polymer that, upon hydrolysis, releases p-bromobenzaldehyde and
p-anisaldehyde at a synergistic 40:60 ratio. The study demonstrated that the polymer
network has potent antimicrobial action and that the aldehydes interact with porins and
multidrug eﬄux pumps of P. aeruginosa. Results of these experiments are presented in
Chapter II.
Although significant progress has been made in the understanding of the
antimicrobial activity of EOs, many aspects of their mode of action remain inconclusive
and are investigated in a limited range of organisms. Thus, the second goal of this work
was to address these gaps by studying cellular targets of p-anisaldehyde and PANDAs in
10

P. aeruginosa PAO1. I carried out a transposon screen of PAO1 for the hypersensitivity
to p-anisaldehyde. I screened several plant-derived efflux pump inhibitors and
demonstrated that epigallocatechin gallate (EGCG), a polyphenol from green tea,
potentiates the activity of p-anisaldehyde against P. aeruginosa. I also used RNA-seq to
study transcriptional responses of P. aeruginosa to p-anisaldehyde, EGCG, and their
combination. My results revealed that p-anisaldehyde induces stress response and targets
membrane transport, synthesis of lipids, energy metabolism, and biosynthesis of the
molybdenum cofactor. EGCG induced oxidative stress and reversed many of the panisaldehyde-coping responses, which may explain its synergistic effect against P.
aeruginosa. Results of these experiments are described in Chapter III and will help to
understand better molecular mechanisms that govern the susceptibility, adaptation, and
resistance of bacteria to antimicrobial phytoaldehydes.
In P. aeruginosa, the N-acyl homoserine lactone-mediated QS represents a crucial
facet of pathogenicity, because it governs the production of multiple virulence factors and
formation of biofilms. Therefore, in the last part of my work, I attempted to potentiate the
antimicrobial action of p-anisaldehyde and aldehyde-based PANDAs by combining them
with furaneol, a natural QS-inhibitor from strawberries. I hypothesized that the presence
of furaneol will trigger the transition of bacteria from the surface-attached biofilm to a
suspended planktonic mode of growth and will render them more susceptible to the
destruction by p-anisaldehyde. Results of my experiments, which are presented in chapter
IV, supported my hypothesis and revealed that pro-antimicrobial polymers containing a
combination of furaneol and p-anisaldehyde inhibited the secretion of QS-regulated

11

virulence factors (pyocyanin and protease), interfered with surface motility, and
eradicated established P. aeruginosa biofilms.
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– USING ALDEHYDE SYNERGISM TO DIRECT THE DESIGN OF
DEGRADABLE PRO-ANTIMICROBIAL NETWORKS
2.1 Abstract
We describe the design and synthesis of degradable, dual-release, proantimicrobial poly (thioether acetal) networks derived from synergistic pairs of aromatic
terpene aldehyde derivatives exhibiting a synergistic antimicrobial activity against
Pseudomonas aeruginosa by determining fractional inhibitory concentrations.
Synergistic aldehydes were converted into dialkene acetal monomers and copolymerized
at various ratios with a multifunctional thiol via thiol−ene photopolymerization. The stepgrowth nature of the thiol−ene polymerization ensures every cross-link junction contains a
degradable acetal linkage enabling a fully cross-linked polymer network to revert into its
small molecule constituents upon hydrolysis, releasing the synergistic aldehydes as active
antimicrobial compounds. A three-pronged approach was used to characterize the poly
(thioether acetal) materials: (i) determination of the degradation/aldehyde release
behavior, (ii) evaluation of the antimicrobial activity, and (iii) identiﬁcation of the
cellular pathways impacted by the aldehydes on a library of mutated bacteria. From this
approach, a polymer network derived from a 40:60 p-bromobenzaldehyde/p-anisaldehyde
monomer ratio exhibited potent antimicrobial action against Pseudomonas aeruginosa,
a common opportunistic human pathogen. From a transposon mutagenesis assay, we
showed that these aldehydes target porins and multidrug eﬄux pumps. The aldehydes
released from the poly (thioether acetal) networks exhibited negligible toxicity to
mammalian tissue culture cells, supporting the potential development of these materials
as dual-release antimicrobial biomaterial platforms.
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2.2 Introduction
The rise in antibiotic resistance among pathogens caused by the overuse of
antibiotics in medicine and agriculture has been identiﬁed by the Infectious Disease
Society of America as a signiﬁcant risk to public health.1,2 The increase in rates of
nosocomial infections caused by pathogens of the ESKAPE group (Enterococcus
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii,
Pseudomonas aeruginosa, and Enterococcus sp.) is particularly alarming, considering
eﬀective treatment options for these infections are rapidly dwindling due to the high
levels of antibiotic resistance.3 Among the members of the ESKAPE group, P.
aeruginosa is associated with respiratory tract infections in patients with cystic
ﬁbrosis and severe hospital-acquired infections associated with surgical wounds and
burns.4−6 P. aeruginosa can eﬄux, inactivate, or modify a wide range of antibiotics,7
prompting the search for alternative therapeutic strategies, including the use of
8−10

antibodies,
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vaccines,

antimicrobial peptides,12 and signaling inhibitors.13−20

Nevertheless, FDA-approved antibiotics and combinations thereof remain the primary
approach for controlling P. aeruginosa infections, but the continuous rise in the
antimicrobial resistance threatens the long-term efficacy of this approach.21−37
Essential oils are plant extracts that contain antimicrobial terpenes, aldehydes, and
terpenoids and have emerged as an effective alternative to antibiotics in combating
pathogenic microorganisms. The antimicrobial constituents of essential oils often exert
multimodal biological activity and can overcome and potentially reverse antimicrobial
resistance.38,39 Prior work has shown that aromatic terpene aldehydes disrupt metabolic
functions in bacteria via membrane disruption,40,41 gene regulation,42 and modification of
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DNA/RNA, proteins, and peptides via Schiff base formation.43 Recently, we
demonstrated the synthesis of degradable poly(thioether acetal) scaffolds, referred to as a
pro-antimicrobial network via degradable acetals (PANDA), using aromatic terpene
aldehydes as building blocks. The PANDA approach helps to circumvent the low
bioavailability, high volatility, and chemical instability of the aldehydes as part of the
poly (thioether acetal) network, but provides controlled release of the antimicrobial
aldehyde upon acetal hydrolysis.44,45 Borrowing from the well-established combination
therapy approach, we hypothesized that synergistic aldehyde pairs could be used to
construct new antimicrobial materials with significantly improved antimicrobial
properties. In this article, we systematically investigated aldehyde combinations to
identify pairs that exhibited antimicrobial synergism. The identified aldehyde pairs were
subsequently converted into diallyl acetal monomers and copolymerized into proantimicrobial networks via degradable acetals (co-PANDAs). The acetal linkages present
throughout the co-PANDAs allow the network to degrade into aldehydes and alcohols
upon exposure to a mild pH (<7.4). To highlight the potential of the new combinatorial
antimicrobial platform, we evaluated the activity and cellular targets of co-PANDAs
against the important opportunistic pathogen P. aeruginosa.
2.3 Materials and methods
2.3.1 Materials
All reagents were obtained from Fisher Scientific at the highest purity available
and used without further purification unless otherwise specified. Pentaerythritol tetra(3mercaptopropionate) (PETMP) was obtained by Bruno Bock. Trimethylolpropane diallyl
ether (90%) was purchased from Sigma-Aldrich. Bacto Tryptone, Difco Agar, and
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Mueller-Hinton (MH) broth and agar were acquired from Becton Dickinson. The MTT
assay kit (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was acquired
from Invitrogen.
2.3.2 Characterization
A Bruker Ascend 600 MHz (TopSpin 3.5) spectrometer was used to record 1H/13C
NMR spectra with chloroform-d. HRMS analysis was completed using positive-ion mode
ionization with an Apollo II ion source on a Bruker 12 T APEX-Qe FTICR-MS.
Dynamic mechanical analysis (DMA, TA Instruments Q800) was performed in tension
mode from −60 to 50 °C at a ramp rate of 3 °C min−1. Real-time Fourier transform IR
(RT-FTIR) spectroscopy (Nicolet 8700 FTIR spectrometer with MCT/A detector; 2 scans
s−1 with a resolution of 4 cm−1) was employed to characterize photopolymerization
kinetics by integrating the thiol (2500−2620 cm−1) and alkene (3050−3125 cm−1) peaks to
determine conversions. UV light (400 mW cm−2) was supplied by an Excelitas Omnicure
S1000. Optical density at 600 nm (OD600) was measured in a BioTek Synergy 2
programmable microplate reader (BioTek Instruments).
2.3.3 Determination of minimum inhibitory concentrations (MICs) of aldehydes
A modified broth microdilution method46 was used to determine the MICs of pA
and pB required to inhibit the growth of P. aeruginosa PAO1. Solutions of pA and pB
ranging in concentration between 0.5 and 3 mg mL−1 were prepared by sonicating for 5
min in the presence of 0.2% agar. Overnight bacterial cultures were then adjusted to 105
CFU mL−1 in 2× Difco Mueller-Hinton (MH) broth. Next, 50 μL aliquots of bacterial
cultures were mixed with equal volumes of aldehyde solutions in a microtiter plate.
Bacteria suspended in MH broth without the addition of aldehydes served as a positive
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control, while 2× MH broth mixed with aldehydes diluted in 0.2% agar served as a
negative control. Microtiter plates were then incubated at 37 °C for 24 h. The MICs were
determined by measuring OD600 with values < 0.05 considered negative for bacterial
growth. Each experiment was repeated three times with three replicates for each
treatment.
2.3.4 Identifying synergistic interactions between EO-derived aldehydes
The synergism assay was done via the checkerboard broth microdilution
technique.47 Briefly, solutions of aldehydes were prepared in 0.2% agar at concentrations
corresponding to 0.5× MIC, 0.25× MIC, and 0.125× MIC. Next, 50 μL of an overnight
bacterial culture adjusted to 105 CFU mL−1 in 2× MH broth were mixed in a microtiter
plate in a checkerboard pattern with 25 μL of two different aldehydes. Bacteria
suspended in MH broth without aldehydes and 2× MH broth mixed with aldehydes
diluted in 0.2% agar served as the positive and negative controls, respectively. Microtiter
plates were incubated at 37 °C for 24 h, and turbidity at 600 nm was measured as
described above. The effect of the checkerboard combinations was determined by
calculating the fractional inhibitory concentration (FIC) index as follows: ΣFIC = (MICA
in combination/MICA alone) + (MICB in combination/MICB alone). The FIC index was
used to interpret the results as follows: FIC index ≤ 0.5 = synergism, 0.5− 0.75 = partial
synergy, > 0.75−1 = additive, > 1− 4.0 = indifference, and > 4.0 = antagonism. All
treatments were done in triplicates, and experiments were repeated at least three times.
2.3.5 Construction of P. aeruginosa PAO1 transposon mutant library
Transposon mutagenesis of P. aeruginosa was performed with EZ-Tn5 <TET-1>
transposon (Lucigen, WI, USA). Briefly, bacteria were cultured overnight in LB broth at
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37 °C with shaking at 250 rpm and prepared for electroporation using the method of Choi
et al.48,49 Then, 100 ng of the EZ-Tn5 <TET-1> DNA was combined with one unit of the
EZ-Tn5 transposase, and 0.7 μL of this mix was electroporated into P. aeruginosa with
an Electroporator 2510 (2.5 kV, 10 μF, 600 Ω) (Eppendorf, NY, USA). The transformed
cells were incubated with shaking for 1.5 h in LB broth and spread-plated on LB agar
supplemented with 100 μg mL−1 of tetracycline. The resultant transposon-bearing clones
were individually transferred into 96-well microplates filled with LB-tetracycline broth,
incubated overnight at 37 °C, mixed with dimethyl sulfoxide (7% final), and frozen at
−80 °C for long-term storage.
2.3.6 Screening transposon mutants hypersensitivity to aldehydes
The transposon mutant library was inoculated into microplates containing 0.2%
MH agar amended with 0.6 × MIC of pA and pB using a 96-prong replicator (VP
Scientific, San Diego, CA). The inoculated microplates were incubated at 37 °C for 24 h,
and bacterial growth was recorded by measuring OD600. The data was normalized by
removing the background absorbance, and a factor of inhibition (F1) was calculated for
each mutant as the reciprocal of the OD600 ratio between the treated and untreated
conditions.50 All mutants with F1 ≥ 9 were identified and retested again with four
different levels (0.6× MIC, 0.8× MIC, 1× MIC, and 1.2× MIC) of pA and pB to confirm
their susceptibility. Controls included the wild-type strain PAO1 and mutants grown in
MH broth in the absence of aldehyde compounds. Assays were repeated twice with two
replicates for each treatment condition.
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2.3.7 Identification of transposon insertion sites
Genomic DNA from susceptible mutants was extracted using the UltraClean
Microbial DNA Isolation Kit (Qiagen, MD, USA). Five hundred nanograms of each
DNA sample were digested to completion with SacII endonuclease and self-ligated with
T4 DNA ligase (both from New England Biolabs, MA, USA). The ligation products
served as a template for inverse PCR with Q5 High-Fidelity DNA Polymerase (New
England Biolabs) and transposon-specific primers TET-1 FP-3 (5′GCATCTCGGGCACGTTGGGTCCT-3′) and TET-1 RP-3 (5′GGGGCTGACTTCAGGTGCTACATTT-3′). The resultant amplicons were cleaned with
a GeneJET PCR purification spin kit (ThermoFisher, MA, USA) and sequenced with
TET-1 FP-3 and TET-1 RP-3 primers. Areas flanking the EZ-Tn5 <TET-1> integration
sites were located by BLAST searches against the reference assembly of P. aeruginosa
PAO1 genome.51
2.3.8 Synthesis of p-anisaldehyde acetal (pAA)
p-Anisaldehyde (pA) was synthesized according to a literature procedure.45,52 1H
NMR (CDCl3, 600 MHz): δ 7.45 (dd), 6.93 (dd), 5.97(m), 5.62 (s), 5.35 (dd), 5.17 (dd),
4.07 (d), 3.82 (s). 13C NMR (CDCl3): δ 159.66, 134.16, 130.68, 127.97, 116.67, 113.52,
100.29, 66.00, and 55.22. HRMS (ESI-FTICR-MS): m / z [M + Na]+ calcd for
C14H18O3Na, 257.114816; found, 257.114844.
2.3.9 Synthesis of p-bromobenzaldehye acetal (pBA)
Trimethylsilyl trifluoromethanesulfonate (TMSOTf) (200 μL, 1.1 mmol) in dry
dichloromethane (30 mL) was added to flame-dried round-bottom flask under nitrogen
and cooled to −84 °C. Allyloxytrimethylsilane (54.5 mL, 324 mmol) and p26

bromobenzaldehyde (pB) (24 g, 129.7 mmol) in 25 mL were then added dropwise, and
the solution was stirred for 3 h. The reaction was then warmed to −30 °C, stirred for 1 h,
and quenched with pyridine (15 mL). The reaction mixture was poured into a saturated
sodium bicarbonate solution (100 mL) and extracted three times with 100 mL of diethyl
ether, and the organic layer was separated and dried over anhydrous MgSO4. The crude
oil collected after rotary evaporation was purified via column chromatography using
ethyl acetate and hexane (1:1). The target compound was a clear oil (79% yield). 1H
(CDCl3, 600 MHz): δ 7.67 (dd), 7.63 (dd), 5.93 (m), 5.66 (s), 5.32 (dd), 5.20 (dd), 4.07
(m). 13C NMR (CDCl3): δ 143.60, 133.97, 132.08, 127.59, 118.62, 117.18, 112.35, and
66.36. HRMS (ESI-FTICR-MS): m / z [M + Na]+ calcd for C13H15BrO2Na, 305.014763;
found, 305.014758.
2.3.10 Synthesis of p-cyanobenzaldehyde acetal (pCyA)
Following the procedure described for p-bromobenzaldehyde, the reaction using
TMSOTf (170 μL, 0.88 mmol), allyloxytrimethylsilane (36 mL, 200 mmol), and pcyanobenzaldehyde (pCy) (11.5 g, 88 mmol) afforded pCyA as a clear oil (8.54 g, 42.5%
yield). 1H NMR (CDCl3, 600 MHz): δ 7.35 (dd), 7.24 (dd), 5.78 (m), 5.45 (s), 5.17 (dd),
5.03 (dd), and 3.90 (dd). 13C NMR (CDCl3): δ 137.54, 134.29, 131.36, 128.55, 122.53,
116.93, 99.76, and 66.13. HRMS (ESI-FTICR-MS): m / z [M + Na]+ calcd for
C14H15NO2Na, 252.099500; found, 252.099407.
2.3.11 Synthesis of p-cinnamaldehyde acetal (CinA)
Following the procedure described for p-cyanobenzaldehyde, the reaction using
TMSOTf (85 μL, 0.44 mmol), allyloxytrimethylsilane (18.5 mL, 110 mmol), and
cinnamaldehyde (Cin) (5.81 g, 44 mmol) afforded CinA as a clear oil (7.47 g, 74% yield).
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Column chromatography was carried out using ethyl acetate, hexane, and triethylamine
(9:0.5:0.5). 1H (CDCl3, 600 MHz): δ 7.42 (dd), 7.34 (m), 6.77 (dd), 6.24 (dd), 5.97 (m),
5.34 (dd), 5.21 (dd), and 4.15 (dd). 13C NMR (CDCl3): δ 136.09, 134.96, 133.41, 128.62,
128.16, 126.79, 127.06, 116.98, 100.34, and 66.26.
2.3.12 General preparation of co-PANDA disks
Pentaerythritol tetra (3-mercaptopropionate) (PETMP), 4 wt % 2-hydroxy-2methylpropiophenone (Darocur 1173), and a mixture of two acetals were added to a
scintillation vial maintaining a 1:1 thiol to alkene ratio. The thiol−ene formulation was
mixed thoroughly, and 30 μL of the mixture was cast between two glass slides separated
with a Teflon spacer (0.76 ± 0.02 mm in thickness). The samples were cured using an
Omnicure S1000-1B with a 100 W mercury lamp (λmax = 365 nm, 320−500 nm filter) at
an intensity of 400 mW cm−2 for 40 s. Control disks were prepared similarly by replacing
the diallyl acetal monomers with trimethylolpropane diallyl ether.
2.3.13 Degradation of co-PANDA disks
Co-PANDA disks (100 mm3) were submerged in a 100 mL solution of
acetonitrile and deionized water (80:20 ratio), and the mixture was continuously shaken
(45 rpm) for 48 h. Then, 500 μL aliquots were removed at 0, 0.25, 0.5, 1, 3, 4, 6, 8, 12,
18, 24, and 48 h and deposited into sealed GC−MS vials. GC−MS analysis was
performed according to previous literature.46 The aldehyde release percentages from the
100 mm3 disks were then applied to estimate the concentration released from a 30 mm3
disk used in the microbial assays. Dark field images were acquired on a Nikon SMZ800N stereomicroscope equipped with a Nikon LED dark field base and a Moticam 1080
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HDMI camera (1/ 2.8″ CMOS sensor). Disk diameters were measured using Motic
Images Plus 3.0 software.
2.3.14 Determining the antimicrobial activity of PANDAs and co-PANDAs via zone
of inhibition assays
Cultures of the wild-type P. aeruginosa PAO1 (WT) and its mexA and oprF
mutants were adjusted in MH broth to OD600 of 0.1. Two hundred microliters of the
diluted bacteria were mixed with 4 mL of molten soft agar maintained at 55 °C, and the
mixture was poured on the surface of MH agar plates. Then, 60 mm3 PANDA disks
(prepared with either pAA or pBA) and co-PANDA disks (prepared with 40:60
pBA/pAA) were fabricated and placed on the overlaid plates. Plates were incubated for
24 h prior to determining the zone of inhibition (ZOI). Three replicates were carried out
for each treatment and each bacterium, and the experiment was repeated twice.
2.3.15 Determining the MIC of PANDAs and co-PANDAs via a broth macrodilution
assay
To determine the optimal pBA/pAA ratio for preparing co-PANDAs, the two
aldehydes were copolymerized at ratios of 100:0, 70:30, 60:40, 50:50, 40:60, 30:70, and
0:100 and compared for the antimicrobial activity. The overnight cultures of the wildtype P. aeruginosa and its mexA and oprF mutants were diluted in MH broth to 105 CFU
mL−1. Four milliliter aliquots of each bacterium were combined with disks of the polymer
material that ranged in size between 10 and 80 mm3 (PANDAs) or between 10 and 40
mm3 (co-PANDAs). MICs of the PANDA and co-PANDA disks were determined after
24 h of incubation at 37 °C.
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2.3.16 Evaluation of kill kinetics via terminal dilution assay
The kill kinetics were determined by measuring the viability of P. aeruginosa
following the exposure to co-PANDAs for 0, 4, 8, 12, and 24 h. Bacterial cultures were
adjusted to 105 CFU mL−1 and combined with 60 mm3 co-PANDA disks in a volume of 4
mL, and the mixtures were incubated with shaking for 24 h at 37 °C. At different time
points, six 100 μL aliquots of bacteria were transferred to a 96-well microtiter plate
prefilled with 200 μL of MHB and serially diluted. The inoculated microtiter plates were
incubated for 48 h at 37 °C, after which the OD600 was measured. The population of
viable bacteria was determined using the following formula:

CFU
mL

=

10 × 3TD
1 mL

where TD

stands for the highest dilution with bacterial growth in microtiter plates. The average of
the six replicates was used to calculate the CFU mL−1.
2.3.17 Direct contact mammalian cell viability test
The effect of the co-PANDAs on mammalian cells was assessed by measuring the
viability of KB cells in a direct contact ISO 10993-5 assay. The KB cells were
maintained and proliferated at 37 °C in 5% CO2 in a humidified atmosphere in the RPMI
1640 medium supplemented with 10% FBS. For viability tests, KB cells (1 M cells
mL−1, 100 μL) were seeded in 96-well microtiter plates, incubated 24 h, and then
overlaid with 6 mm3 co-PANDA disks. Treatments exposed to 6 mm3 nondegradable
thiol−ene control disks were used as a control, and cells with no treatment served as a
blank reference. Three replicates were measured to calculate percent survival and
standard deviation. After 24 h incubation, cell viability was determined using a Vybrant
MTT Cell Proliferation Assay Kit (Invitrogen) following the manufacturer’s protocol.
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MTT absorbance was measured using a Biotek Synergy2 microplate reader. All assays
were performed in triplicate, and the experiment was repeated twice.

Scheme 2.1 Outline of the Approach for Designing an Antimicrobial Material from
Screening Synergistic Aldehyde.
2.4 Results and discussion
The overall experimental strategy is outlined schematically in Scheme 2.1. This
strategy involved screening aldehyde pairs for antimicrobial synergy, followed by direct
conversion of aldehydes into polymerizable dialkene acetal monomers. The acetal
monomers were then copolymerized at different ratios into cross-linked polymer
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networks and subsequently used to (i) determine concentrations of released aldehydes,
(ii) evaluate the antimicrobial activity of the copolymerized networks, and (iii) identify
microbial pathways targeted by individual aldehydes, as well as their combinations in the
wildtype and mutant derivatives of P. aeruginosa. Initially, we identified synergistic
combinations of aldehydes by measuring the fractional inhibitory concentration (FIC) of
cinnamaldehyde (Cin), p-cyanobenzaldehyde (pCy), p-anisaldehyde (pA), pchlorobenzaldehyde (pCl), and p-bromobenzaldehyde (pB) pairs against P. aeruginosa
PAO1 (Table 1). From the screening, only Cin/pA (FIC = 0.75), pB/pCy (FIC = 0.75),
and pB/pA (FIC = 0.75, Figure 2.1a), pairs exhibited partial synergism and served as raw
material candidates for degradable matrix synthesis. The synergistic aldehydes were
converted into polymerizable acetal monomers with allyloxytrimethylsilane in the
presence of trimethylsilyl trifluoromethanesulfonate in reasonable yields (∼40−55% after
column). The resulting dialkene acetal monomers (e.g., p-bromobenzaldehyde acetal
(pBA) and p-anisaldehyde acetal (pAA), cinnamaldehyde acetal (CinA) and panisaldehyde acetal (pAA), and p-bromobenzaldehyde acetal (pBA) and pcyanobenzaldehyde acetal (pCyA)) were then copolymerized into polymer networks in a
variety of ratios with a tetrafunctional thiol cross-linker (PETMP) at a 1:1 SH/ene
stoichiometry.
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Summary of Synergistic Screening of Aldehyde Pairs.
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Figure 2.1 Antimicrobial properties of small molecules and matrices.
(a) Graph showing synergistic interactions between pB and pA against P. aeruginosa PAO1. The highlighted box shows the
determined synergistic concentrations and molar ratio of pA and pB at the FIC value used in this study. (b) Optical density
measurements as a function of disk size for co-PANDA pBA/pAA matrices of different ratios. The highlighted box indicates the most
effective synergistic composition of pB and pA, which was used throughout the study.

Preliminary degradation studies were carried out in 1 N HCl simply to accelerate
the degradation process. Under these conditions, networks composed of 50:50
pBA/pCyA and 50:50 CinA/pAA both required greater than 2 days to reach the point of
visual degradation. Real-time FTIR studies revealed that CinA/pAA was the only
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composition in which the SH exhibited complete conversion, while the alkene did not
fully polymerize (Figure A.1 a, b). We speculate that the internal alkene of CinA could be
a competing site for radical addition, which would lead to the formation of irreversible
cross-links and thereby slow rate of degradation. Additionally, the rate of acetal
degradation increases with decreasing pH, and therefore, the 2-day onset of degradation
for both pCB/pCyA and CinA/pAA under 1 N HCl conditions precludes their use as a
release platform against P. aeruginosa (growth conditions ∼ pH 7). However, 50:50
pBA/pAA disks degraded even under PBS (pH 7.4); thus, the pBA/pAA system remained
the primary focus in subsequent antimicrobial tests. Additionally, the pBA/pAA coPANDA resins reached a high conversion upon UV exposure (Figure A.2) and yielded
materials with a glass transition temperature below room temperature (Figure A.3). The
antimicrobial properties of pBA/pAA matrices that comprised different acetal mole ratios
were compared by establishing the minimum amount of co-PANDA material required for
the complete inhibition of P. aeruginosa PAO1 after an overnight exposure (Figure 2.1b).
Results of this experiment revealed that at a 30 mm3 disk size all co-PANDAs exhibited a
lower P. aeruginosa OD600 reading (lower OD600 reading = lower bacterial concentration)
than PANDAs containing either only pAA or pBA. Moreover, among all of the tested
pBA/pAA ratios, the 40:60 co-PANDA required the smallest disk size (30 mm3) to
achieve full inhibition of P. aeruginosa PAO1, compared to the other co-PANDAs (MICs
= 40−50 mm3), pure pAA (80 mm3) and pBA (50 mm3) PANDA disks. The fact that the
40:60 co-PANDA required the smallest disk size to inhibit the growth of P. aeruginosa
PAO1 is not coincidental, as this ratio closely matched the synergistic 34:66 pB/pA mole
ratio determined from the aldehyde FIC study (as previously shown in Figure 2.1a). This
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result suggests that both aldehydes are released from the 40:60 pBA/pAA co- PANDA at
concentrations similar to the FIC study. The concentration of aldehydes released from the
40:60 pBA/pAA co-PANDA over time was measured by GC−MS.
Due to low solubility of both aldehydes in water, an 80:20 acetonitrile/H2O
mixture was necessary to ensure sink conditions for aldehyde release. The co-PANDA
disks (100 mm3) were submerged in a sealed vial with 100 mL of degradation media, and
aliquots were removed and analyzed via GC−MS to determine the concentrations of pA
and pB released over time (Figure 2.2a). Although the degradation media is not identical
to growth media in the bacteria experiments, the concentrations/percent released obtained
from the release data are assumed to be similar and serve as an estimate for the
concentration of aldehydes released to the bacteria. Within the first hour, the co-PANDA
disks released 0.71 ± 0.11 mg mL−1 of pB (29% acetal degradation) and 1.02 ± 0.12 mg
mL−1 of pA (41% acetal degradation). After the initial burst release, the degradation
begins to slow over the full 48 h study. The determined release values (0.71 ± 0.11 mg
mL−1 of pB and 1.02 ± 0.12 mg mL−1 of pA) were in excellent agreement with the FIC
values for both pB (0.69 mg mL−1) and pA (1.00 mg mL−1) corroborating that the 40:60
co-PANDA disk released the synergistic pair of aldehydes near the concentration
necessary to inhibit bacteria observed in the testing of small molecule experiments.
Additionally, dark field optical micrographs of a 40:60 co-PANDA disk exposed to the
same degradation medium were used to determine the average co-PANDA disk diameter
over time. As shown in Figure 2.2b, the average disk diameter rapidly decreases within
the first 5 h, which coincides with the burst release observed in the GC− MS data (Figure
2.2a). After the initial burst, both the optical images and GC−MS show a slower change
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in disk diameter and aldehyde released. From an antimicrobial perspective, the burst
release of both pA and pB at inhibitory concentrations is essential for exerting synergistic
antimicrobial activity. It is important to state that if the disks did not burst to inhibitory
concentrations, no significant antimicrobial activity would be observed. Additionally, the
slow release kinetics observed after the initial burst (> 4 h), limits the 40:60 co-PANDA’s
ability to continually deliver inhibitory levels of aldehydes over the long term.
Despite the progress in the understanding of the biological activity of plant
terpene aldehydes, these compounds have been investigated in a limited range of
microorganisms and many aspects of their antimicrobial action remain inconclusive. We
addressed these gaps by conducting an analysis of cellular pathways targeted by pA and
pB and their co-PANDA matrices in P. aeruginosa. Screening a small transposon
insertion library of P. aeruginosa for tolerance to subinhibitory concentrations (0.6×
MIC) of pA and pB yielded 141 mutants with an increased sensitivity (factor of inhibition
F1 ≥ 1) to one or both aldehydes. Nineteen mutants with F1 values of ≥ 9 were selected
for further work and identification of genes affected by transposon insertions (Figure
A.4). Results of the analysis revealed that pA and pB target a diverse range of
cytoplasmic and membrane pathways, including those involved in the central
intermediary metabolism, biosynthesis of cofactors, and various transport functions.
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Figure 2.2 Degradation behavior for 40:60 pBA/pAA co-PANDA disks in 80:20
ACN/H2O.
(a) Determined amounts and percentages of pA and pB released from co-PANDA disks (n = 5). (b) Average disk diameters measured
from dark field images (inset images) taken over time (n = 5). Scale bar = 0.5 mm. The blue line is inserted to guide the reader’s eye.

The hypersusceptibility phenotype was linked to genes operating in global
regulation, twinarginine (Tat) protein secretion pathway, respiratory chain, biosynthesis
of molybdenum cofactor, and transport of various small molecules and antimicrobials.
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Several mutants were deficient in the production of conserved hypothetical proteins. We
are currently working on a paper that will present the detailed analysis of these pathways
and discuss the effects of phytoaldehydes on the transcriptome of P. aeruginosa. Here,
we further concentrated our attention on two mutants that carried mutations in genes
encoding porin proteins OprF and MexA, which are components of the multidrug efflux
pump MexAB−OprM (Figure A.4). Both proteins play an essential role in the intrinsic
and adaptive resistance of P. aeruginosa to a variety of antimicrobial agents. The major
porin OprF mediates the passage of small hydrophilic molecules and contributes to the
low outer membrane permeability in this pathogen.53 Rapid efflux of antimicrobials by
the resistance-nodulation-cell division (RND) systems, such as MexAB−OprM
complements the action of P. aeruginosa porins.54 Although previous studies implicated
OprF and MexAB−OprM as important determinants of resistance to several classes of
antibiotics,55 our results are the first to report that outer membrane porins and RND efflux
pumps play a crucial role in the resistance of P. aeruginosa to aromatic terpenes.
We further employed the oprF and mexA mutants to assess the susceptibility of P.
aeruginosa to pBA- and pAA-containing polymer materials. The zone of inhibition (ZOI)
assays revealed that the inactivation of oprF and mexA increased the sensitivity to both
PANDA and co-PANDA matrices (Figure 3a). Importantly, the co-PANDA disks
simultaneously releasing both pA and pB created a larger zone of inhibition in all tested
strains compared to PANDA disks of equal size that were synthesized with only pBA or
pAA. In contrast, the control disks (no degradable acetals) did not exhibit antimicrobial
activity against any of the bacterial strains. To determine the minimum inhibitory
concentrations, we cultured the wild-type P. aeruginosa and its mexA and oprF mutants
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in liquid growth medium in the presence of 40:60 pBA/pAA co- PANDA disks of
different sizes. Results of this experiment demonstrated that a co-PANDA disk of 30
mm3 was sufficient to inhibit the growth of both mutants and the wild-type strain (Figure
2.3b). Overall, the mexA-deficient strain exhibited the highest sensitivity to the coPANDA disks followed by the oprF mutant and the wild-type strain, which agreed with
results of the screening for susceptibility to pA and pB (Figure A.4). To investigate
whether the co-PANDAs exert a bactericidal or bacteriostatic effect, we exposed P.
aeruginosa to 60 mm3 co- PANDA disks for varying times and estimated the number of
viable bacteria by a terminal dilution assay (Figure 2.3c). After 12 h of exposure, the coPANDA disks exhibited a bactericidal 5 log reduction in bacterial concentration, while
the control disks were unable to inhibit the growth of bacteria. In general, the mutants
were more susceptible to co-PANDA than the wild-type parental strain (mexA > oprF >
WT). These findings were in good agreement with results of the screening of transposon
mutants for sensitivity to aldehydes, where the mexA mutant was more sensitive to both
aldehydes than its oprF counterpart.

40

Figure 2.3 Antimicrobial action of PANDAs and the 40:60 pBA/PAA co-PANDAs
against the wild-type P. aeruginosa PAO1 and its mexA and oprF mutant.
(a) Zone of inhibition assay. (b) Minimum inhibition disk size assay. (c) Kinetic bactericidal assay. Controls were a nondegradable
thiol−ene disk of the same size. The upper dashed line represents the initial bacterial concentration as a reference, while the lower
dashed line represents the limit of detection for the assay.

41

Finally, an MTT assay with KB cells (a type of HeLa cell) was used to assess the
cytotoxicity of the 40:60 pBA/pAA co-PANDA material. The co-PANDA disk size was
scaled down to 6 mm3 for the MTT assay with 104 cells in 100 μL well volumes. The
results of the assay, shown in Figure 2.4, revealed that the 40:60 pBA/pAA co-PANDA
caused a decrease in the cell viability to 76% relative to the blank. However, the viability
was still above 70%, which meets the ISO 10993-5 criteria for cytocompatibility for
materials. A bright field image of control cells (no treatment) after 24 h is shown in
Figure 2.4b. Bright field images of the KB cells incubated with a co-PANDA showed no
signs of cell lysis, reduction of growth, or zones of inhibition after 24 h of exposure to the
40:60 pBA/pAA co-PANDA disks (Figure 2.4c).56

Figure 2.4 MTT cytocompatibility results of co-PANDA materials.
(a) HeLa cells challenged with either a 40:60 pBA/pAA co-PANDA, a nondegradable control, or a blank control. The lower limit of
viability for cytocompatibility established by ISO 10993-5 (0.7 × negative control) is represented by the dashed line. (b) Bright field
image of control cells (no treatment) after 24 h. (c) Bright field image of cells incubated with a co-PANDA disk after 24 h.

2.5 Conclusion
In summary, we have shown a rational design for a dual-release antimicrobial
material. The synergistic screening of multiple aldehydes led to a few select pairs that
were converted into monomers and then copolymerized into cross-linked co-PANDAs.
After the co-PANDA degradation behavior was understood, the pBA/pAA co-PANDA
emerged with the greatest potential for antimicrobial activity (MIC levels released within
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1 h). The most potent co-PANDA ratio (40:60 pBA/pAA) closely matched the most
potent aldehyde synergy ratio (36:64 pB/pA). The antimicrobial activity of the 40:60
pBA/pAA co-PANDA was evaluated against wild-type and mexA and oprF mutants of P.
aeruginosa. Both mutants were more susceptible to aldehydes than the parental strain,
suggesting that outer membrane porins and MDR efflux pumps play an important role in
resistance of P. aeruginosa to antimicrobial terpene aldehydes. Lastly, co-PANDAs
exhibited negligible toxicity to mammalian tissue culture cells. These degradable, dualrelease antimicrobial materials should elicit interest for a broad range of biomaterial
applications (e.g., wound care, surgical tool coatings, etc.).
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(23) Berditsch, M.; Jäger, T.; Strempel, N.; Schwartz, T.; Overhage, J.; Ulrich, A. S.
Synergistic Effect of Membrane-Active Peptides Polymyxin B and Gramicidin S
on Multidrug-Resistant Strains and Biofilms of Pseudomonas Aeruginosa.
Antimicrob. Agents Chemother. 2015, 59 (9), 5288−5296.
(24) Ejim, L.; Farha, M. A.; Falconer, S. B.; Wildenhain, J.; Coombes, B. K.; Tyers, M.;
Brown, E. D.; Wright, G. D. Combinations of Antibiotics and Nonantibiotic Drugs
Enhance Antimicrobial Efficacy. Nat. Chem. Biol. 2011, 7 (6), 348−350.
(25) Cherian, P. T.; Deshpande, A.; Cheramie, M. N.; Bruhn, D. F.; Hurdle, J. G.; Lee, R.
E. Design, Synthesis and Microbiological Evaluation of Ampicillin−Tetramic Acid
Hybrid Antibiotics. J. Antibiot. 2017, 70 (1), 65−72.
(26) Lambert, R.; Hanlon, G.; Denyer, S. The Synergistic Effect of EDA/Antimicrobial
Combinations on Pseudomonas aeruginosa. J. Appl. Microbiol. 2004, 96 (2),
244−253.
(27) Lyu, Y.; Domalaon, R.; Yang, X.; Schweizer, F. Amphiphilic Lysine Conjugated to
Tobramycin Synergizes Legacy Antibiotics Against Wild-Type and MultidrugResistant Pseudomonas aeruginosa. Pept. Sci. 2018, e23091.
(28) Jenkins, R.; Cooper, R. Improving Antibiotic Activity Against Wound Pathogens
with Manuka Honey In Vitro. PLoS One. 2012, 7 (9), No. e45600.
(29) Borselli, D.; Lieutaud, A.; Thefenne, H.; Garnotel, E.; Pagès, J.- M.; Brunel, J. M.;
Bolla, J.-M. Polyamino-Isoprenic Derivatives Block Intrinsic Resistance of P.
aeruginosa to Doxycycline and Chloramphenicol In Vitro. PLoS One. 2016, 11
(5), No. e0154490.

47

(30) Zheng, Z.; Tharmalingam, N.; Liu, Q.; Jayamani, E.; Kim, W.; Fuchs, B. B.; Zhang,
R.; Vilcinskas, A.; Mylonakis, E. Synergistic Efficacy of Aedes Aegypti
Antimicrobial Peptide Cecropin A2 and Tetracycline Against Pseudomonas
aeruginosa. Antimicrob. Agents Chemother. 2017, 61 (7), e00686.
(31) Chan, B. K.; Sistrom, M.; Wertz, J. E.; Kortright, K. E.; Narayan, D.; Turner, P. E.
Phage Selection Restores Antibiotic Sensitivity In MDR Pseudomonas aeruginosa.
Sci. Rep. 2016, 6 (26717), 1−8.
(32) Chaudhry, W. N.; Concepción-Acevedo, J.; Park, T.; Andleeb, S.; Bull, J. J.; Levin,
B. R. Synergy and Order Effects of Antibiotics and Phages in Killing
Pseudomonas aeruginosa Biofilms. PLoS One. 2017, 12 (1), No. e0168615.
(33) Duncan, B.; Li, X.; Landis, R. F.; Kim, S. T.; Gupta, A.; Wang, L.-S.; Ramanathan,
R.; Tang, R.; Boerth, J. A.; Rotello, V. M. Nanoparticle-Stabilized Capsules for the
Treatment of Bacterial Biofilms. ACS Nano. 2015, 9 (8), 7775−7782.
(34) Zhitnitsky, D.; Rose, J.; Lewinson, O. The Highly Synergistic, Broad Spectrum,
Antibacterial Activity of Organic Acids and Transition Metals. Sci. Rep. 2017, 7
(44554), 1−13.
(35) Breidenstein, E. B.; de la Fuente-Núñez, C.; Hancock, R. E. Pseudomonas
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–THE ANTIMICROBIAL ACTIVITY AND CELLULAR PATHWAYS
TARGETED BY P-ANISALDEHYDE AND EPIGALLOCATECHIN GALLATE IN
THE OPPORTUNISTIC HUMAN PATHOGEN PSEUDOMONAS AERUGINOSA.
3.1 Abstract
Plant-derived aldehydes are constituents of essential oils that possess broadspectrum antimicrobial activity and kill microorganisms without promoting resistance. In
our previous study, we incorporated p-anisaldehyde from star anise into a polymer
network called PANDAs (Pro-Antimicrobial Networks via Degradable Acetals) and used
it as a novel drug delivery platform. PANDAs released p-anisaldehyde upon a change in
pH and humidity, and controlled growth of the multi-drug resistant pathogen
Pseudomonas aeruginosa PAO1. In this study, we identified cellular pathways targeted
by PANDAs, by generating 10,000 transposon mutants of PAO1 and screened them for
hypersensitivity to p-anisaldehyde. To improve the antimicrobial efficacy of panisaldehyde, we combined it with epigallocatechin gallate (EGCG), a polyphenol from
green tea, and demonstrated that it acts synergistically with p-anisaldehyde in killing P.
aeruginosa. We then used RNA-seq to profile transcriptomic responses of P. aeruginosa
to p-anisaldehyde, EGCG, and their combination of thereof. The exposure to panisaldehyde altered the expression of genes involved in the modification of cell
envelope, membrane transport, drug efflux, energy metabolism, molybdenum cofactor
biosynthesis, and stress response. We also demonstrated that the addition of EGCG
reversed many p-anisaldehyde-coping effects and induced oxidative stress. Our results
provide an insight into the antimicrobial activity of p-anisaldehyde and its interactions
with EGCG and may aid in the rational identification of new synergistically acting
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combinations of plant metabolites. Our study also confirms the utility of the thiol-ene
polymer platform for the sustained and effective delivery of hydrophobic and volatile
antimicrobial compounds.
3.2 Introduction
Pseudomonas aeruginosa is a ubiquitous gram-negative bacterium that serves as
an important model for opportunistic infections and biofilm research 34,35. This organism
is commonly found in soil, water, and plants, but can readily infect immunocompromised
individuals causing septicemia and wound or urinary tract infections 8. It also responsible
for pneumonia and causes increased morbidity and mortality in cystic fibrosis patients. P.
aeruginosa is resistant to multiple classes of antibiotics and belongs to a class of
pathogens with increased virulence, persistence and transmissibility known as the
ESKAPE group (also encompasses Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, and Enterobacter species) 10. The
Centers for Disease Control and Prevention (CDC) reports that, in the U.S. alone, P.
aeruginosa is associated with 8% of all hospital-acquired infections and over 400 deaths
per year, which are often caused by multi-drug resistant (MDR) strains 30. These MDR
variants are insensitive to nearly all the available β-lactams and aminoglycosides and are
classified by the CDC as a serious threat that requires close monitoring and prevention
activities 53. Therefore, there is a need for the development of antimicrobial agents, which
do not promote antibiotic resistance and may help to mitigate the spread of MDR
phenotypes in P. aeruginosa and other bacterial pathogens.
Plant essential oils (EOs) represent a rich source of alcohols, aldehydes, terpenes,
ethers, ketones, and phenolic compounds with antimicrobial, antifungal, and antiparasitic
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activity 23. The antiseptic properties and low toxicity of EOs prompted their use in
traditional food preservation and folk medicine 43. However, despite the demonstrated
biological activity, the wider acceptance of EOs and their constituents as antimicrobial
agents is limited by the hydrophobicity, chemical instability, high concentrations needed
to achieve sufficient antimicrobial effect, and lack of understanding of the mode of
action. In our previous work, we addressed some of these issues by incorporating the
antimicrobial EO constituent p-anisaldehyde into a polymer network called PANDAs
(Pro-Antimicrobial Networks via Degradable Acetals)

3,5

. The resultant polymer material

was designed to act as a pro-drug that releases p-anisaldehyde upon a change in pH and
humidity. The incorporation into PANDAs increased the bioavailability and antimicrobial
efficacy of p-anisaldehyde and related phytoaldehydes against P. aeruginosa,
Escherichia coli, Burkholderia cenocepacia, Staphylococcus aureus, and Candida
albicans. We also demonstrated that the inactivation of the MexAB-OprM multidrug
efflux pump sensitizes P. aeruginosa to the action of p-anisaldehyde.
MexAB-OprM is a member of the resistance-nodulation-cell-division (RND)
superfamily of multidrug efflux pumps, which are recognized as essential contributors to
the emergence of MDR phenotypes in pathogenic bacteria. These membrane transporters
extrude a broad spectrum of antimicrobial compounds 17, intercellular signals, and
virulence factors 2,40, which makes them an attractive target for the development of antiresistance drugs. Such drugs, known as efflux pump inhibitors (EPIs), interfere with the
function, expression, or assembly of RND pumps, and can significantly reduce or
completely reverse resistance against otherwise ineffective antibiotics 47. Despite the
development of a number of effective synthetic and semi-synthetic EPIs, none of these
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compounds are currently used in the treatment of bacterial infections because of the
instability, low selectivity, and cytotoxic side effects 48. Plants, like animals, are attacked
by bacterial pathogens and have evolved defense mechanisms to counteract such
infections. This fact has prompted numerous plant-based studies aimed at the isolation of
natural EPIs with lower toxicity and better tolerability. These efforts produced a growing
list of promising candidates, some of which were patented and are being evaluated
against different pathogens 15,41.
In this study, we used P. aeruginosa PAO1 as a model to identify cellular
pathways targeted in bacterial pathogens by p-anisaldehyde and structurally related
compounds. We first subjected PAO1 to transposon mutagenesis and screened the
resultant library of mutants for susceptibility to sub-inhibitory concentrations of panisaldehyde and the new p-anisaldehyde-containing antimicrobial polymer. This new
polymer network relies solely on diffusion to control the release of the active panisaldehyde from a non-degradable thiol-ene thermoset matrix. The synthesis of the
polymer was performed using only commercially available polyfunctional alkenes and
polyfunctional thiols, which have eliminated the need to prepare and purify hydrolytically
unstable monomers required for release of p-anisaldehyde. The new approach minimized
the susceptibility of the monomers to atmospheric conditions during the network cure
process and improved the batch-to-batch variability. The resultant polymer material had
antimicrobial efficacy nearly identical to that of the previously reported degradable
systems 3,5.
We also screened a panel of plant-derived EPIs for the ability to potentiate the
antimicrobial activity of phytoaldehydes and demonstrated that epigallocatechin gallate
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(EGCG), a polyphenol from green tea, acts synergistically with p-anisaldehyde and
significantly reduces its minimal inhibitory concentration against P. aeruginosa. Finally,
we profiled the transcriptomes of P. aeruginosa grown in the presence of p-anisaldehyde,
EGCG, and a combination of thereof to gain insight into the possible mode of action of
these plant-derived antimicrobial compounds. Our results revealed that p-anisaldehyde
alters the expression of genes involved in the membrane transport, lipids biosynthesis,
stress response, energy metabolism, and biosynthesis of the molybdenum cofactor. The
addition of EGCG reversed many of the p-anisaldehyde-coping responses and induced
oxidative stress, which may contribute to the synergistic antimicrobial effect against P.
aeruginosa.
3.3 Materials and Methods
3.3.1 Bacterial strain, growth conditions and compounds
All experiments conducted in this study were performed with the reference strain
Pseudomonas aeruginosa PAO1. The organism was routinely cultured at 37 °C in Difco
Luria-Bertani (LB) medium (Becton Dickinson, Franklin Lakes, NJ), while MuellerHilton II (MH) broth and agar (Becton Dickinson) were used for all antimicrobial assays.
The selection of transposon mutants was performed by amending the growth medium
with tetracycline (Tc) (Thermo Scientific, Waltham, MA) at the concentration of 100 μg
mL-1. p-Anisaldehyde (pA), epigallocatechin gallate (EGCG), geraniol, daidzein,
berberine, curcumin, 2-hydroxy-2-methylpropionate (Darocur 1173), and 1,3,5-triallyl1,3,5-triazine-2,4,6(1H,3H,5H)-trione (TTT) were obtained from Thermo Scientific in the
highest purity available and used without further purification. The stock solution of panisaldehyde was prepared by ultrasonicating the compound for 5 min in 0.2% (w/v)
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agar. The stock solutions of EGCG (10 mg mL-1), geraniol (5 mg mL-1), daidzein (5 mg
mL-1), berberine (2 mg mL-1), and curcumin (5 mg mL-1) were prepared by dissolving the
chemicals in dimethyl sulfoxide (DMSO) (Alfa Aesar, Haverhill, MA).
3.3.2 Construction of the transposon mutant library
The transposon mutagenesis was conducted by electroporating P. aeruginosa with
transposomes, which are stable complexes formed between the EZ-Tn5 <TET-1>
transposon and the EZ-Tn5 Transposase (both from Lucigen, Middleton, WI). Briefly,
cells from an overnight culture of PAO1 were collected and washed twice in 0.3 M
sucrose. One hundred microliters of electrocompetent bacteria, equivalent to 1010 viable
cells, were mixed with 0.7 µL of the EZ-Tn5™ <TET-1> transposomes in a 2-mm gap
width electroporation cuvette. The mixture was electroporated with an Electroporator
2510 (Eppendorf, Hauppauge, NY) at 2.5 kV, 10 μF, and 600 Ω. The transformed cells
were immediately suspended in LB broth, incubated with shaking at 37 °C for 1.5 h,
spread plated onto LB-Tc100, and incubated at 37 °C until the appearance of individual
colonies. The tetracycline-resistant colonies were transferred individually into 96-well
microtiter plates prefilled with LB broth amended with 7% DMSO and stored at -80 °C.
A total of 10,000 transposon-bearing mutants were collected, which is estimated to cover
approximately 83% of the PAO1 genome using the formula: 𝑚 = 1 − 𝑒 −𝐿/𝐺 , where G is
equal to the number of genes in the PAO1 genome (5,572 protein-coding genes) and for a
given size library (L)

13

.
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3.3.3 Screening of the transposon library for the sensitivity to p-anisaldehyde
The transposon mutants of PAO1 were screened for hypersensitivity to panisaldehyde by replicating the library with a 96-prong replicator (VP Scientific, San
Diego, CA) into microplates pre-filled with MH broth supplemented with 0.6 MIC (1.2
mg mL-1), 0.75 MIC (1.5 mg mL-1), and 0.85 MIC (1.7 mg mL-1) of p-anisaldehyde.
The inoculated plates were incubated at 37 °C for 24 h, and bacterial growth was
recorded by measuring optical density at 600 nm (OD600) using a Synergy 2 reader
(BioTek Instruments, Winooski, VT). The sensitivity of individual mutants was
determined by defining their factor of inhibition (F1) values, which are calculated as the
reciprocal of the OD600 ratio between the treated and untreated conditions

13

. All mutants

with F1 values of ≥ 9 were considered as hyper susceptible to p-anisaldehyde. The
screening was performed twice in duplicates for each tested concentration of panisaldehyde.
3.3.4 Mapping transposon insertion sites in hypersensitive mutants
Genomic DNA was extracted from overnight cultures of the sensitive mutants
grown in LB broth using a DNeasy UltraClean Microbial Kit (Qiagen, Germantown,
MD), and 250 ng of the DNA was digested with the restriction endonuclease SacII (New
England Biolabs, MA, USA). The endonuclease reaction was incubated for 3 hours at 37
°C, and the enzyme was inactivated at 65°C for 20 min. The digested DNA was selfligated with T4 DNA ligase (New England Biolabs) by incubating it overnight at 16°C.
The ligation products served as a template for inverse PCR with the Q5 High-Fidelity
DNA Polymerase (New England Biolabs), and transposon-specific primers (Table 1).
Cycling conditions included 98 °C for 30 s, followed by 34 cycles of 98 °C for 10 s, 72
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°C for 2 min and 72 °C for 2 min, and a final extension at 72 °C for 5 min. The PCR
amplicons were purified using a GeneJET PCR Purification Kit (Thermo Scientific) and
sequenced at Eurofins MWG Operon (Huntsville, AL). Areas flanking the EZ-Tn5
<TET-1> integration sites were mapped to the P. aeruginosa PAO1 genome using the
BLASTn web tool of the Pseudomonas database.17
3.3.5 Synthesis of p-anisaldehyde-releasing polymeric discs
A stock resin solution was prepared by adding 2 g of TTT (8.04 mmol, 24.12
mmol ene), 2.95 g of PETMP (6.03 mmol, 24.12 mmol SH), and 118 mg Darocur 1173
(0.72 mmol, 3 mol percent relative to SH) to a scintillation vial and mixing thoroughly.
Two-gram portions of the resin were then mixed with 800 mg p-anisaldehyde (28.6 wt
%) to form the active resin. Eighty microliter aliquots of resin were dispensed onto glass
slides spaced with Teflon spacers (0.75 mm in thickness) and cured using an OmniCure
S1000-1B light source (Lumen Dynamics, Mississauga, Ontario, Canada) with a 100 W
mercury lamp (λmax = 365 nm, 320–500 nm filter) for 20 s at an intensity of 200 mW
cm-2. Control disks were prepared in the same fashion from the stock resin. Network
conversion was confirmed via kinetic data collected through real-time FTIR (RT-FTIR)
spectroscopy to monitor the disappearance of thiol and alkene functional groups. RTFTIR spectra were recorded using a Nicolet 8700 FTIR spectrometer (Thermo Scientific)
equipped with a KBr beam splitter and MCT/A detector using an OmniCure S1000 320–
500 nm filtered ultraviolet light source. Each sample was exposed to a UV light with an
intensity of 200 mW cm-2. Series scans were collected with a data spacing of 2 scans per
second with a resolution of 4 cm-1. Thiol conversion was monitored via integration of the
SH peak between 2500 and 2620 cm-1 and alkene conversion was monitored via the peak
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between 3050 and 3125 cm-1. Evaluating the sensitivity of transposon mutants to the of panisaldehyde-releasing polymeric discs
The antimicrobial activity of polymeric discs against the wild type PAO1 strain
and select hypersensitive mutants was determined via a zone of inhibition (ZOI) assay.
Briefly, overnight bacterial cultures were adjusted to OD600 of 0.1, and then further
diluted 1:5 with fresh MH broth. Aliquots (200 µL) of diluted bacterial suspensions were
mixed with 4 mL of lukewarm molten soft agar and overlaid on MH agar, after which an
80 mm3 p-anisaldehyde polymeric disc was placed at the center of each inoculated plate.
Plates were incubated for 24 h at 37 °C, and the ZOI was measured in mm. In order to
compare the sensitivity of mutants, the average ZOI of each mutant was normalized to
that of the WT strain, which represented the level of sensitivity of 100%. All treatments
were replicated three times, and each mutant was tested twice.
3.3.6 Screening plant-derived EPIs for synergistic interactions with p-anisaldehyde
Several plant-derived EPIs were evaluated for the synergistic antimicrobial
activity with p-anisaldehyde using a modified broth microdilution technique 4. This was
done by determining the MIC of p-anisaldehyde against P. aeruginosa PAO1 in the
presence of non-inhibitory concentrations of EGCG (150 µg mL-1), daidzein (1 mg mL-1),
curcumin (400 µg mL-1), berberine (400 µg mL-1), or geraniol (600 µg mL-1). The
positive control was treated with the uncoupler of proton motive force carbonyl cyanide
m-chlorophenylhydrazone (CCCP) (25 µg mL-1), whereas the negative control was
treated with p-anisaldehyde, and bacteria cultured in the unamended MH medium served
as growth control. The assay was conducted in 96 well-microtiter plates, which were
incubated at 37 °C for 24 hours before measuring OD600 to determine the nature of
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interactions (OD600 < 0.05 was considered negative for bacterial growth). Each
experiment was repeated three times, with three replicates per treatment.
3.3.7 Confirmation of synergistic interactions between EGCG and p-anisaldehyde
The synergistic interaction between EGCG and p-anisaldehyde was verified using
a broth microdilution checkerboard technique. Stock concentrations of both compounds
were diluted to MIC, ½ MIC, ¼ MIC, and 1/8 MIC, which corresponds to 300, 150, 75
and 37.5 µg mL-1 for EGCG, and 2, 1, 0.5 and 0.25 mg mL-1 of p-anisaldehyde. Next, 25µL aliquots of both compounds were combined in a checkerboard manner with 50 µL of
bacterial suspension adjusted to 105 CFU mL-1. Negative control included both
compounds mixed with MH broth, while bacteria grown in the absence of EGCG and panisaldehyde served as a positive control. Microtiter plates were incubated at 37 °C for
24 h, and OD600 was measured to determine the fractional inhibitory concentration (FIC)
3

, with FIC ≤ 0.5 and FIC ≥ 4 indicating, respectively, synergism and antagonism. Each

treatment included three replicates, and the entire experiment was repeated three times.
3.3.8 Extraction and processing of RNA
Overnight broth culture of WT P. aeruginosa PAO1 was diluted to an OD600 0.01,
after which 100 µL aliquots of the bacterial suspension were dispensed into wells of a 96
well-microtiter plate and incubated statically at 37 °C. At an OD600 of 0.6, each microtiter
plate well received 100 µL of MH broth amended with ½ MIC concentrations of panisaldehyde (1 mg mL-1), EGCG (150 µg mL-1), or a combination of both compounds.
The experiment included three biological replicates of each treatment plus a control,
which was cultured in unamended MH broth. After 1 h of exposure to antimicrobials at
37 °C, approximately 2.5  108 cells were fixed by mixing with two volumes of
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RNAprotect Bacteria Reagent (Qiagen), and total RNA was extracted using RNeasy Mini
Kit (Qiagen) according to the manufacturer’s instructions. Total RNA was treated with
RNase-free DNase I (Ambion, Austin, TX) and purified with RNA Clean and
Concentrator-25 columns (Zymo Research, Irvine, CA). The concentration of RNA was
measured using a NanoDrop OneC spectrophotometer (Thermo Scientific) and a
QuantiFlour RNA System (Promega, Madison, WI), while its integrity was determined
using an Agilent 2100 Bioanalyzer and an RNA 6000 Nano Kit (both from Agilent
Technologies, Santa Clara, CA). Samples of total RNA (RIN > 9; A260/280 ratio ~2.0)
were shipped to the Center for Genome and Research and Biocomputing (Oregon State
University, Corvallis, OR), where they were treated with a Ribo-Zero rRNA Removal Kit
(Bacteria) (Illumina, San Diego, CA), and the efficacy of ribodepletion was confirmed
using a Bioanalyzer RNA 6000 Pico Kit (Agilent Technologies). The stranded RNA-Seq
libraries were prepared, quantified by qPCR, and sequenced on a HiSeq 3000 instrument
(Illumina) in 150 bp single-end mode.
3.3.9 Bioinformatic analysis of transcriptomic data
The analysis of RNA-seq data was performed using the KBase suite of expression
analysis tools 7. Briefly, the raw reads in fastq format were filtered and processed with
Trimmomatic 9, and the quality of filtered data was assessed with FastQC
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The processed reads were
then aligned to the reference PAO1 genome (GenBank accession number NC_002516.2,
downloaded from http://www.pseudomonas.com) with HISAT2-v2.10 25, and full-length
transcripts were assembled with StringTie v1.3.3b39. The differential expression analysis
of the assembled transcripts was carried out with DESeq2 v1.20.032, and genes
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demonstrating greater than a 1.5-fold (log2) difference in expression and an adjusted p
value ≤ 0.05 between control and experimental treatments were used in downstream
analysis. The functional annotation and gene enrichment analysis were performed with
the Blast2GO suite.20
3.3.10 RT-qPCR analysis of genes encoding components of RND efflux pumps
The response of P. aeruginosa RND efflux pump genes to p-anisaldehyde,
EGCG, and a combination of both compounds was validated by the quantitative reverse
transcription PCR (RT-qPCR). Briefly, 1 μg of total RNA was converted to cDNA using
the iScript Reverse Transcription Supermix (Bio-Rad, Hercules, CA, USA), and used in
the RT-qPCR assay performed with the Luminaris Probe qPCR Master Mix (Thermo
Scientific) and oligonucleotide primers and probes targeting mexA, mexC, mexE, mexX,
mexK, muxB, and PA1541 (Table A.1). Samples of RNA untreated with reverse
transcriptase served as a negative control to confirm the absence of contaminating
genomic DNA. The analysis was performed with a CFX96 Real-Time PCR Detection
System and CFX Maestro software (Bio-Rad). The expression of selected RND efflux
genes was normalized to that of the housekeeping gene rpoD.
3.4 Results
3.4.1 Selection and characterization of mutants with hypersensitivity to panisaldehyde
The screening of the transposon mutant library yielded 39 clones that failed to
grow in the presence of p-anisaldehyde. All hypersensitive mutants had F1 values ≥ 9 and
were at least 1.2 times more sensitive to p-anisaldehyde than the wild type PAO1 strain
(Fig. 3.1A). Most of these mutants were sensitive to 1.5 mg mL-1 of p-anisaldehyde
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(0.75 MIC of the wild type strain), while the growth of two mutants was completely
inhibited at 1.2 mg mL-1. The hypersensitive mutants were further tested for the
sensitivity to the p-anisaldehyde-containing polymeric discs. Our results confirmed that
most of them were significantly more sensitive to the polymeric discs (P < 0.05), with the
most sensitive mutants manifesting a 2.6-fold increase in the zone of inhibition compared
to the WT strain (Fig. 3.1B). The mapping of transposon insertion sites by inverse PCR
and DNA sequencing revealed that the sensitivity to p-anisaldehyde was caused by
mutations in 27 unique P. aeruginosa genes. The majority (40%) of the affected genes
function in the energy metabolism and generation of ATP or participate in the uptake of
molybdenum and synthesis of the molybdenum cofactor (Table 3.1). Other identified
genes are involved in signal transduction, nucleotide metabolism, or membrane transport
of small molecules. Interestingly, among mutants with increased sensitivity to panisaldehyde-containing polymeric discs were two isolates that carried mutations in
mexB, which encodes the periplasmic linker component of the RND efflux pump
MexAB-OprM (Table 3.1).
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Figure 3.1. The sensitivity of transposon mutants to p-anisaldehyde.
(A) The distribution of F1 values of mutants after first round of screening. Red dots indicate mutants with F1 ≥ 9 that were selected
for further analysis. (B) The inhibition of growth caused by p-anisaldehyde polymeric discs in selected transposon mutants (F1 ≥ 9)
and the wild type PAO1 strain. Asterisks indicate mutants that were more sensitive to p-anisaldehyde than parental strain (one-tailed ttest at P<0.05).

65

Genes disrupted by EZ-Tn5<TET-1> in transposon mutants with increased sensitivity to p-anisaldehyde.
Functional category PA number Gene name Predicted function
Membrane transport

PA1777

oprF

Outer membrane porin F

1

PA3000

aroP1

Aromatic amino acid permease

1

Major facilitator superfamily (MFS) transporter

1

PA3336

Signal transduction

PA5068

tatA

Sec-independent protein translocase

2

PA0928

gacS

Two-component sensor kinase

1

Two-component sensor kinase

1

PA3271

Energy metabolism

Number of mutants

PA4856

retS

Hybrid sensor histidine kinase/response regulator

1

PA1554

ccoN1

Cbb3-type cytochrome c oxidase subunit I

1

Nucleotide-binding protein

1

Phosphoenolpyruvate-protein phosphotransferase

2

PA1880

Probable oxidoreductase

2

PA2993

FAD:protein FMN transferase

1

PA4465
PA0337

ptsP

PA2994

nqrF

Na(+)-translocating NADH-quinone reductase subunit F

3

PA2995

nqrE

Na(+)-translocating NADH-quinone reductase subunit E

1

Table 3.1 (Continued)
Functional category

PA number

Gene name

Predicted function

PA2999

nqrA

Na(+)-translocating NADH-quinone reductase

Number of mutants
3

subunit A
Transport of molybdenum

PA1861

modC

Molybdenum import ATP-binding protein

3

and synthesis of Mo co-

PA1862

modB

Molybdenum transport system permease

1

factor

PA3028

moeA2

Molybdopterin molybdenumtransferase

2

PA3029

moaB2

Molybdenum cofactor biosynthesis protein B

1

PA4663

moeB

Molybdopterin biosynthesis MoeB protein

1

PA0425

mexA

MexAB-OprM efflux system, periplasmic linker

2

Response to antibiotics

component
PA5485

ampDh2

N-acetylmuramoyl-L-alanine amidase

1

Nucleotide metabolism

PA0590

apaH

Bis(5'-nucleosyl)-tetraphosphatase

1

and modification

PA2991

sth

Soluble pyridine nucleotide transhydrogenase

1

PA5339

ridA

2-aminoacrylate deaminase

1

PA4617

rRNA large subunit methyltransferase G

1

PA4618

Hypothetical protein

2

Unknown

3.4.2 Epigallocatechin gallate potentiates the activity of p-anisaldehyde in P.
aeruginosa
Since the transposon screen suggested the possible importance of RND efflux
pumps for the resistance to phytoaldehydes, we tested a panel of known plant-derived
EPIs for the ability to sensitize P. aeruginosa to p-anisaldehyde. The testing involved
measuring the MIC of p-anisaldehyde in the presence of non-inhibitory concentrations of
selected EPIs. Results of that screen revealed that the addition of daidzein had no effect,
while berberine, curcumin, and geraniol exhibited partial synergism and moderately
decreased the MIC of p-anisaldehyde in the wild-type PAO1 (Table 3.2). In contrast, the
green tea polyphenol epigallocatechin gallate (EGCG) significantly reduced the MIC of
p-anisaldehyde and exhibited a strong synergistic effect similar to that of the proton
motive force uncoupler CCCP. Broth microdilution checkerboard assay between EGCG
and p-anisaldehyde confirmed that both compounds interact synergistically with the
∑FIC value of 0.5 (data not shown).
The effect of plant-derived EPIs on the MIC of p-anisaldehyde in P. aeruginosa
PAO1.
EPI

Concentration
(μg mL-1)

MIC of p-anisaldehyde
(mg mL-1)

Type of
interaction

None

N/A

2.0

N/A

CCCP

25

0.6

Synergism

EGCG

150

0.8

Synergism

Daidzein

400

2

Indifference

Berberine 400

1.5

Synergism

Curcumin 400

1.5

Synergism

Geraniol

1.5

Synergism

400
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3.4.3 The effect of p-anisaldehyde on the transcriptome of P. aeruginosa PAO1
In order to gain further insight into the antimicrobial activity of p-anisaldehyde,
we profiled and compared transcriptomes of P. aeruginosa treated with p-anisaldehyde,
EGCG, and a combination of both compounds. The RNA-seq generated a total of 554
million filtered reads, which were mapped to the reference PAO1 genome. Statistical
analysis using the cut off criteria of |log2FC|≥1.5 and FDR ≤ 0.05 revealed that the
highest number of differentially expressed genes (DEGs) was associated with exposure to
p-anisaldehyde, which affected the expression of 264 genes, or 5% of the entire genome
(Fig. 3.2A). The treatment with EGCG and a combination of both compounds altered,
respectively, the expression of 28 and 86 genes. We also performed the pairwise
comparison between the p-anisaldehyde and combination treatments to understand
molecular mechanisms responsible for the synergistic effect of epigallocatechin gallate.
P. aeruginosa responded to p-anisaldehyde by upregulating the expression of 128
genes, many of which function in energy metabolism, membrane transport, signal
transduction, and stress response. The overall highest levels of induction were observed
in genes encoding components of RND multidrug efflux pumps, the two-component
response regulator PhoP (PA1179), and several conserved hypothetical proteins. The 137
downregulated genes included those encoding various transporters, and components of
energy metabolism pathways, type III secretion apparatus, and respiratory nitrate
reductase. Interestingly, a significant proportion (32%) of DEGs that responded to panisaldehyde genes encoded conserved hypothetical proteins of unknown function. We
also matched the genes that were differentially expressed in response to p-anisaldehyde to
genetic loci identified during the transposon screen. Results of this comparison revealed
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that the two datasets shared three genes, which encoded a cytochrome oxidase (PA1554),
a predicted oxidoreductase (PA1880), and a two-component sensor (PA3271) (Fig. 3.2B).
The Blast2GO analysis of p-anisaldehyde DEGs identified the intrinsic component
of the membrane, plasma membrane, and cell periphery as dominant GO terms in the
cellular component category. The most common GO terms in molecular function and
biological processes categories were, respectively, the binding of an organic cyclic
compound, and cellular metabolic processes (Fig. 3.3A). A similar pattern of GO terms
was observed in the Blast2GO profiling of genes interrupted by insertions of the EZ-Tn5
<TET-1> transposon in p-anisaldehyde-sensitive mutants. Finally, the gene enrichment
analysis of upregulated DEGs revealed the overrepresentation (Fisher’s exact test; FDR ≤
0.05) of genes involved in the biosynthesis of lipids and response to chemicals and
antibiotics. In contrast, the downregulated DEGs were enriched in genes associated with
ion transmembrane transport and translation (Fig. 3.3B).
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Figure 3.2 Venn diagram comparing the number of differentially expressed genes
between P. aeruginosa exposed to p-anisaldehyde, EGCG, and the combination of
thereof.
(A) The comparison of genes implicated in the response to p-anisaldehyde in transposon mutants and cultures profiled by RNA-seq
(B).
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Figure 3.3. GO classification of DEGs in response to p-anisaldehyde.
(A) Functional annotation analysis of DEGs and transposon mutagenesis genes. (B) Gene enrichment analysis of DEGs using the
Fishers exact test (FDR ≤ 0.05).

3.4.4 EGCG modulates transcriptional changes caused by p-anisaldehyde in P.
aeruginosa
In contrast to p-anisaldehyde, the exposure of PAO1 to subinhibitory levels of
epigallocatechin gallate altered the expression of only 28 genes, one-third of which were
classified as conserved hypothetical. Among the upregulated DEGs with predicted
functions were those encoding the RND efflux pump MuxABC-OpmB, transcriptional
regulators (PA2525-PA2528 and PA2825), and components of the cell envelope and
oxidative stress defense systems (PA0848, PA0849, PA4612, and PA4613). The six
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downregulated DEGs encoded a DNA mismatch repair protein (PA4946), an MFS
transporter (PA2314), 1-phosphofructokinase (PA3561), and a FAD-binding subunit of
glycolate oxidase (PA5354). The common GO terms in the cellular component category
were linked with cell envelope, while the molecular function was associated with binding
of heterocyclic compounds, oxidoreductase activity, transporter and peroxidase activity
(Fig. 3.4A). The dominant biological processes involved the response to chemical,
regulation of cellular processes, and cellular detoxification. Gene enrichment analysis
showed that most EGCG DEGs were involved in response to toxic substances and
oxidative stress, while downregulated genes were associated with lipid biosynthesis and
carbohydrate metabolism (Fig. 3.4B).
Interestingly, the treatment of P. aeruginosa with a combination of p-anisaldehyde
and EGCG altered the expression of 86 genes. The majority of these genes (76 in total)
were also present in p-anisaldehyde or EGCG datasets, and only 11 were uniquely
associated with the mixed treatment (Fig. 3.2A). Three of these unique DEGs were
downregulated and encoded a hypothetical protein (PA5406), a ribosomal protein
(PA4433), and the cell division protein FtsE (PA0374). The unique upregulated genes
encoded a hydrocarbon reductase (PA5236), an MFS transporter (PA5030), and a
fosfomycin resistance protein (PA1129). The gene enrichment analysis of the
combination treatment revealed an overrepresentation of DEGs involved in the
transmembrane transport, response to antibiotics and efflux, iron binding, and peptide
biosynthesis (Figure 3.5).
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Figure 3.4. Gene ontology (GO) classification of P. aeruginosa genes that were
differentially expressed in response to epigallocatechin gallate (A), and gene enrichment
analysis of EGCG DEGs using Fishers exact test (FDR ≤ 0.05) (B).
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Figure 3.5 Gene ontology (GO) classification of P. aeruginosa genes that were
differentially expressed in response to a combination of p-anisaldehyde and
epigallocatechin gallate (A), and gene enrichment analysis of DEGs using Fishers exact
test (FDR ≤ 0.05) (B).
3.4.5 The interaction between p-anisaldehyde and EGCG affects multiple categories
of cellular pathways in P. aeruginosa
Our transcriptomic analysis revealed that p-anisaldehyde strongly induced genes
encoding the RND efflux pumps MexCD-OprJ, MexEF-OprN, and MexKJ, as well as the
putative transporter of the small multidrug resistance (SMR) family PA1541.
Additionally, genes that encode regulators of the mexAB-oprM operon (i.e., the repressor
gene mexR (PA3720), the antirepressor gene armR (PA3719), and nalC (PA3721)) were
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differentially expressed in p-anisaldehyde-treated cells. In contrast, the treatment with
EGCG induced only one RND pump, MuxABC, suggesting that this transporter plays a
specific role in the efflux of epigallocatechin gallate. We further validated the RNA-seq
data by RT-qPCR with oligonucleotide primers and probes targeting components of
seven clinically relevant P. aeruginosa efflux pumps. The results of this experiment
revealed a strong induction of mexC, mexE, and mexK in response to p-anisaldehyde,
which was in agreement with the results of RNA-seq (Fig. 3.6). Interestingly, although,
mexC, mexE, and mexK were also upregulated in the combination treatment, the addition
of EGCG resulted in significantly lower levels of expression compared to the panisaldehyde-only treatment. Contrary to results of the transposon mutagenesis, we failed
to detect any measurable induction of genes encoding components of the MexAB-OprM
efflux pump. We attribute this discrepancy to differences in the length of the exposure to
p-anisaldehyde between the transposon screen and gene expression experiments.

76

Figure 3.6. Relative expression of RND-type efflux pump genes in response to panisaldehyde, EGCG, and a combination of both compounds.
Bars with different letters indicate significant differences in gene expression as determined by Tukey-Kramer HSD test (P < 0.05).

In addition to RND pumps, we observed that the presence of p-anisaldehyde
modulated the expression of almost 30 other membrane transporter genes. The
enrichment analysis of these DEGs revealed an overrepresentation of pathways
associated with the transmembrane transport of ions and inorganic molecules (Fig. 3.3B).
Like in the case of RND pumps, some of these genes were also differentially expressed
between the p-anisaldehyde and p-anisaldehyde/EGCG treatments. The comparison of
gene expression profiles also revealed five ABC transporter genes (agtA, agtB, ihpM,
gltG, and yrbE) that were downregulated by p-anisaldehyde, but that effect was
significantly reversed in cultures treated with a combination of p-anisaldehyde and
EGCG (Fig. 7). The effect was especially pronounced in the case of yrbE (PA4455),
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which encodes an ABC transporter involved in resistance to acidified nitrite, EDTA, and
several antibiotics 33. A similar response to p-anisaldehyde and EGCG was observed in
genes encoding components of the potassium translocating ATPase KdpFABC.
Conversely, the addition of EGCG significantly induced the cation diffusion facilitator
(CDF) transporter gene yiiP, whose expression was unaffected by p-anisaldehyde.
Our analysis also revealed that p-anisaldehyde and EGCG differentially modulate
the activity of several genes involved in the modification of the P. aeruginosa cell
envelope. The exposure to p-anisaldehyde induced genes of the arnBCADTEF cluster,
which functions to modify the lipid A component of the lipopolysaccharide thereby
leading to increased resistance to cationic antimicrobial peptides 26. This induction was
not observed in the EGCG-treated cells, and the treatment with both compounds
significantly reduced the expression of arnBCF (Fig. 3.7). Similar alterations were
observed in the expression level of the oprH-phoPQ operon, which encodes an outer
membrane protein H and a two-component signal transduction system that regulates the
activity of the arnBCADTEF operon 19. Interestingly, oprH, which was induced by panisaldehyde but expressed weaker in the presence of EGCG, represents part of the Mg2+
stimulon and contributes to the resistance to polymyxin B and aminoglycosides 18.
p-anisaldehyde and EGCG differentially affected expression of multiple cellular
pathways associated with the stress response. The comparative analysis revealed that
genes encoding several oxidative stress response enzymes, molecular chaperones, and a
component of the DNA mismatch repair system were differentially expressed between
the p-anisaldehyde, EGCG, and combination treatments. The EGCG and combination
treatments upregulated genes encoding the KatB catalase (PA4613) 11 and its accessory
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ankyrin-like protein AnkB (PA4612)

22

, the alkyl hydroperoxide-reducing protein AhpB

(PA0848), the thioredoxin reductase TrxB2 (PA0849) 45, and two proteins, PA3237 and
PA3287, that are upregulated in response to H2O2

1,37

(Fig. 3.7). In contrast, p-

anisaldehyde upregulated the expression of molecular chaperones GroES and GroEL, but
this effect was reversed by the presence of EGCG. In mutL, which functions to stabilize
components of the mismatch repair machinery, the combination treatment completely
negated the effect of individual p-anisaldehyde and EGCG treatments, which both
strongly downregulated this gene.
Finally, our results revealed that the treatment with p-anisaldehyde and EGCG
modulated the expression of the narK1K2GHJI operon (PA3872-PA3877), which
encodes the respiratory nitrate reductase and nitrate transporter (Fig. 3.7). Whereas panisaldehyde significantly repressed genes of the nitrate reductase pathway, the
combination treatment significantly reduced this effect, while EGCG alone has little
effect on the expression of this pathway.
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Figure 3.7. Changes in the P. aeruginosa transcriptome in response to p-anisaldehyde,
EGCG, and the combination of both compounds.
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3.5 Discussion
In this study, we used a combination of transposon mutagenesis and RNA-seq to
characterize cellular pathways targeted by p-anisaldehyde and epigallocatechin gallate in
the multidrug-resistant human pathogen P. aeruginosa. p-anisaldehyde is a constituent of
essential oils and a member of the phenylpropanoid family of metabolites, which are
synthesized by plants as derivatives of the amino acid phenylalanine 54. Therefore, our
findings provide insight into the biological activity of a larger group of structurally
related compounds with antimicrobial, antifungal, and antibiofilm properties 24,44.
Although the antimicrobial activity of EOs is traditionally attributed to their ability to
affect the integrity of cellular membranes 36, our results revealed that p-anisaldehyde
interferes with a much broader range of cellular pathways. We observed that the exposure
to p-anisaldehyde resulted in the downregulation of genes encoding cytochrome oxidases
(cyoA, ccoN1), a phosphofructokinase (fruK), a pyruvate carboxylase (pycA), and the
NADH:ubiquinone oxidoreductase NqrAEF. In the course of our transposon screen, we
recovered several mutants with defects in genes involved in the transport of molybdenum
and biosynthesis of the molybdenum cofactor. Molybdenum cofactor is an essential
component of several important molybdoenzymes, including respiratory nitrate
reductases 29. Our transcriptomic data revealed that exposure to p-anisaldehyde
significantly downregulated the narK1K2GHJI operon that in P. aeruginosa encodes
components of the inner membrane-bound nitrate reductase complex. This dissimilatory
nitrate reductase catalyzes the respiratory reduction of nitrate to nitrite and helps generate
ATP in the absence of oxygen 52. Interestingly, nitrate reduction decreases the trans fatty
acid content and inhibits the formation of biofilms in P. aeruginosa 38. The biofilm
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lifestyle and alterations in the fatty acid profile are associated with the response to
environmental stress and toxic substances 21. Hence, it is plausible that the repression of
nitrate reductase represents a defense response to p-anisaldehyde by favoring the
formation of resistant biofilms and densely packed membranes with higher trans fatty
acid content.
Other notable categories of defense response to p-anisaldehyde in P. aeruginosa
included the upregulation of molecular chaperones and efflux transport. The treatment
with p-anisaldehyde upregulated genes encoding chaperons DnaK, DnaJ, and GroES,
which function to refold and destroy damaged proteins and are induced by heat shock,
oxidative stress, disinfectants, heavy metals, and antibiotics 14,28,57. We further observed
an upregulation of betAB genes (PA5372, PA5373) that encode enzymes involved in the
conversion of choline to glycine betaine, a key microbial compatible solute. The
intracellular accumulation of glycine betaine and related compounds confers tolerance to
osmotic, thermal, oxidative, and denaturant forms of stress 12,42,55. Our transposon screen
and RNA-seq also revealed that p-anisaldehyde upregulates multiple transporters and
including efflux pumps of the RND superfamily. We also observed the induction of genes
encoding the MexCD-OprJ, MexEF-OprN, and MexKJ efflux pumps, and recovered a
transposon mutant with a defect in MexAB-OprM. These pumps expel antibiotics,
metabolic inhibitors, detergents, biocides, quorum sensing signals, and some virulence
factors 27,46. A recent study by Tetard et al. 51 reported the upregulation of the same group
of RND pumps in P. aeruginosa PA14 treated with cinnamaldehyde. Taken collectively
with our results, this observation strongly suggests that active efflux represents a key
mechanism of resistance to antimicrobials of the phenylpropanoid group. In addition to
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efflux pumps, P. aeruginosa harbors an extensive array of intrinsic (chromosomallyencoded) and imported (encoded by mobile elements) serine-based and metallo-βlactamases and aminoglycosides inactivating enzymes, which contribute to the
emergence of MDR (multidrug-resistant), XDR (extensively drug-resistant), and even
PDR (pandrug-resistant) strains 8. Our experiments with p-anisaldehyde revealed no
changes in the expression of genes involved in the enzymatic inactivation of antibiotics,
thus supporting the notion that essential oils may be useful in curbing the spread of
antibiotic resistance.
Individual EO constituents are often less potent than antibiotics, which presents
practical problems for their use as antimicrobials or food preservatives. A possible way to
overcome this obstacle involves the exploitation of synergistic effects between different
EO constituents. Although a number of synergistic combinations of compounds were
identified by trial and error 23, the molecular mechanisms behind such interactions remain
poorly understood. The results of this study may help to address this gap in knowledge by
probing synergistic interactions between p-anisaldehyde and EGCG. The RNA-seq
profiling revealed that the two compounds target very different sets of cellular pathways
in P. aeruginosa. Interestingly, we included EGCG in our experiments as a potential
efflux pump inhibitor 49,50, and then observed the induction of the RND efflux pump
MuxABC-OpmB. Although the expression of other efflux pump genes was not affected
(or even somewhat repressed in cultures treated with a combination of p-anisaldehyde
and EGCG), we feel that the EPI properties of epigallocatechin gallate should be
investigated further. The analysis of genes differentially expressed in the presence of
EGCG also revealed components of several pathways (katB, ahpB, trxB2, PA2826,
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PA3237, PA3287) that are associated in P. aeruginosa with the response to oxidative
stress and exposure to H2O2 1. These findings provide an insight into the antimicrobial
mode of action of epigallocatechin gallate and agree with reports of the intercellular
release of H2O2 in E. coli O157:H7 treated with subinhibitory levels of EGCG
results of Liu et al.

31

16

, and

, who profiled the transcriptomic response of P. fluorescens to

EGCG. Surprisingly, apart from the oxidative stress genes, our RNA-seq data did not
significantly overlap with the P. fluorescens dataset, which had over 400 genes whose
expression was altered in response to EGCG. We attribute these discrepancies to
differences in the biology of the two Pseudomonas species, higher concentrations of
EGCG used by Liu et al. 31, and more stringent fold change cutoff used in our study
(|log2FC|≥1.5 vs. |log2FC|≥1) to identify the differentially expressed P. aeruginosa genes.
Collectively, our results suggest that p-anisaldehyde affects P. aeruginosa by first
interfering with the integrity of its cell envelope, which then allows it to accumulate
intracellularly and adversely affect proteins, by causing their misfolding and aggregation.
In contrast, epigallocatechin gallate poisons bacteria by inducing oxidative stress, which
may explain its ability to complement and potentiate the antimicrobial action of panisaldehyde. The synergistic antimicrobial effect is further enhanced by the capacity of
EGCG to partially or completely reverse the upregulation of many genes by panisaldehyde, including those encoding various transporters and key RND efflux pumps.
Interestingly, the treatment with a combination of p-anisaldehyde and EGCG also
significantly repressed a gene (PA0374) encoding FtsE, which is membrane protein
located in the septal ring. This may represent yet another facet of the synergism because
studies in E. coli and several other species demonstrated that ftsE mutants grow poorly
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and exhibit division defects 6. In gram-negative bacteria, the failure to complete cell
division is associated with increased sensitivity to antibiotics, detergents, and defensins
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.
In conclusion, this study provides an insight into the antimicrobial activity of p-

anisaldehyde and its synergistic interactions with epigallocatechin gallate. Our results
may aid in the rational identification of new synergistically acting combinations of plant
metabolites and their exploitation for the control of pathogenic microorganisms. Our
study also confirms the utility of the thiol-ene polymer platform for the sustained and
effective delivery of hydrophobic and volatile antimicrobial compounds.
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– SYNTHESIS AND FUNCTIONAL EVALUATION OF PROANTIMICROBIAL POLYMERS THAT TARGET THE PRODUCTION OF
BIOFILMS AND VIRULENCE FACTORS IN THE HUMAN PATHOGEN
PSEUDOMONAS AERUGINOSA
4.1 Abstract
Pseudomonas aeruginosa is a ubiquitous gram-negative opportunistic pathogen
that poses a significant threat to public health. This organism has a large repertoire of
regulatory genes, an impressive array of virulence traits, and forms antibiotic-resistant
biofilms that make infections difficult to eradicate. In P. aeruginosa, the production of
many virulence factors is regulated in the cell density-dependent way by quorum sensing
(QS). The QS also controls the synthesis of rhamnolipids, which mediate the formation of
microcolonies during the biofilm establishment, as well as growth and dispersion of
mature biofilms. In this study, we combined furaneol (a natural plant-derived QS
inhibitor) with p-anisaldehyde (an antimicrobial constituent of essential oil from star
anise) to disrupt quorum sensing and biofilm formation in P. aeruginosa PAO1. We
hypothesized that furaneol would trigger the transition of bacteria from the recalcitrant
surface-attached biofilm to the suspended planktonic mode of growth, which would
render them vulnerable to destruction by p-anisaldehyde. Results of our experiments
revealed that the treatment of P. aeruginosa with furaneol effectively disrupted the
secretion of QS-regulated virulence factors, surface motility, and formation of static
biofilms. We then used thiol-ene chemistry to produce antimicrobial polymers, which
enable high loading, efficient “encapsulation,” and sustained release of furaneol and panisaldehyde. The exposure of P. aeruginosa PAO1 to furaneol/p-anisaldehyde
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polymeric discs strongly repressed the production of pyocyanin, reduced the exoprotease
activity, prevented bacteria from colonizing the solid surface, and completely eradicated
established biofilms. Our results will facilitate the development of polymeric systems
capable of dual phytochemical delivery and controlling microbial growth without
promoting antibiotic resistance.
4.2 Introduction
Pseudomonas aeruginosa is a ubiquitous gram-negative opportunistic pathogen
that causes life-threatening infections in individuals with burn wounds, cancer, cystic
fibrosis, and AIDS.1,2 This organism utilizes numerous organic compounds as energy
sources, has a large repertoire of regulatory genes, and an impressive array of virulence
traits, which collectively allow P. aeruginosa to successfully adapt to both environmental
and pathogenic lifestyles.3 Moreover, the ability of P. aeruginosa to form biofilms
enhances its resistance to antimicrobial agents and makes infections very difficult to
eradicate.4 In many bacterial pathogens, the successful colonization of a host organism
requires intimate contact between bacterial cells and host tissues. In P. aeruginosa, the
contact with rigid surfaces induces virulence in multiple models of infection.5 The initial
contact with host tissues involves type IV pili, which are the most important adhesin of P.
aeruginosa. In addition to binding to the host epithelial cells, type IV pili are also
involved in special forms of surface motility known as twitching and swarming.6 The
twitching motility uses only type IV pili, which act as grappling hooks that pull the
bacterial cell along a solid surface, whereas the swarming motility uses type IV pili,
flagella, and rhamnolipids, and is induced by certain N and C sources. Both twitching and
swarming types of motility are linked to the formation of P. aeruginosa biofilms.7
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Quorum sensing (QS) is an intercellular mechanism of communication that allows
bacteria to coordinate gene expression in response to cell density. This regulatory
mechanism involves the production, sensing, and response to signaling molecules called
autoinducers (AIs), which bind to their cognate response regulators that affect the
transcription of target genes.2,8–10 In P. aeruginosa, QS governs the production of many
virulence factors, especially those involved in acute infections.11 Quorum sensing also
controls the synthesis of rhamnolipids, which mediate the formation of microcolonies
during the biofilm establishment, as well as growth and dispersion of mature biofilms.12
Structural components of the biofilm EPS matrix, such as polysaccharide Pel and
extracellular DNA, are also under QS control. P. aeruginosa produces three different
autoinducer molecules: N-(3-oxo-dodecanoyl)-L-homoserine lactone, N-butyryl-Lhomoserine lactone, and 2-heptyl-3-hydroxy-4-quinolone. These autoinducers control,
respectively, the Las, Rhl, and PQS parts of the QS network.2,8,10 Due to the high clinical
relevance of regulated traits and the absence of homologs in humans and higher animals,
QS is considered a promising target for adjuvant therapy of P. aeruginosa infections.11
Several strategies have been suggested for the interference with QS in P.
aeruginosa, including the inhibition and degradation of AI synthesis, inhibition of AI
binding to response regulator, and competitive exclusion of AIs.4 The use of compounds
that compete with AIs for target receptors represents an intuitive way of disrupting the
function of QS circuits, and the identification of such AI mimics can be performed in a
high-throughput fashion using libraries of small molecules.13 Living organisms represent
a rich source of potential AI analogs, and numerous active agonists and antagonists of QS
were discovered in bacteria, fungi, and especially plants. For example, brominated
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furanones in the red algae Delisea pulchra were among the first recognized small
molecule inhibitors of QS.14 The original discovery prompted chemical synthesis
research that produced dozens of halogenated furanone compounds, many of which
exhibit excellent activity at disrupting QS in P. aeruginosa and Aliivibrio fischeri.15
Unfortunately, halogenated furanones proved to be toxic, which precludes their
application for therapeutic purposes.4 Recently, a natural furanone compound, 4hydroxy-2,5-dimethyl-3-furanone (also known as furaneol, or strawberry furanone), was
shown to interfere with QS traits in P. aeruginosa.16 Unlike its halogenated counterparts,
furaneol is a non-toxic metabolite and used in the perfume industry and as a food
flavoring agent.
In this study, we combined furaneol with the antimicrobial essential oil
constituent p-anisaldehyde to produce antimicrobial polymer materials capable of
disrupting quorum sensing and biofilm formation in P. aeruginosa. Our previous research
has identified the plant polyphenol epigallocatechin gallate (EGCG) as a compound that
potentiates the antimicrobial activity of p-anisaldehyde (Adewunmi et al., unpublished).
Hence, in this work, we also tested the efficacy of epigallocatechin gallate (EGCG) in
combination with p-anisaldehyde against P. aeruginosa biofilms. The efficient target
delivery of furaneol and p-anisaldehyde was achieved by incorporating them into a thiolene polymer network, an approach that we successfully used in previous studies to
stabilize hydrophobic and volatile plant antimicrobials.17,18 However, in contrast to
previously used pro-antimicrobial polymers that require degradation in order to release panisaldehyde, we describe here the synthesis of a non-degradable thiol-ene thermoset
matrix that relies solely on diffusion to control the release of bioactive compounds. We
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then evaluated the ability of the new polymer containing furaneol and p-anisaldehyde to
interfere with QS and disrupt the release of virulence factors and formation of biofilm in
the reference strain P. aeruginosa PAO1.
4.3 Materials and Methods
4.3.1 Materials, bacterial strains, and culture conditions
Pseudomonas aeruginosa PAO1 was used in all experiments listed in this study.
The strain was routinely cultured at 37℃ in Luria-Bertani (LB) medium, while the
Mueller-Hilton II (MH) broth and agar (all from Becton Dickinson, Franklin Lakes, NJ)
were used in all antimicrobial assays. The production of pyocyanin production was
measured in King’s medium A (KMA).19 p-Anisaldehyde, 2-hydroxy-2-methylpropionate
(Darocur 1173), 1,3,5-triallyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione (TTT), EGCG, and
4-Hydroxy-2,5-dimethyl-3(2H)-furanone (furaneol) were obtained from Thermo Fisher
Scientific (Waltham, MA) in the highest purity available and used without further
purification. Pentaerythritol tetrakis (3-mercaptopropionate) (PETMP) was provided by
Bruno Bock (Marschacht, Germany) and used as supplied. As needed, 10 mg mL-1 stock
concentrations of p-anisaldehyde, EGCG, and furaneol were prepared in fresh MHB,
DMSO, and water, respectively.
4.3.2 Static biofilm assays
We measured the activity of p-anisaldehyde, EGCG, furaneol, and their respective
combinations on surface-attached biofilms formed by P. aeruginosa PAO1 using the
protocol of O’Toole.20 Overnight bacterial cultures were adjusted to an OD600 of 0.1 and
then diluted 1:10 in MHB supplemented with furaneol (3 mg mL-1), EGCG (150 µg mL1

), p-anisaldehyde (1 mg mL-1), a combination of p-anisaldehyde and EGCG (1 mg mL-1
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and 150 µg mL-1, respectively), or a combination of p-anisaldehyde and furaneol (1 and 3
mg mL-1, respectively). One hundred microliter aliquots of diluted bacteria were
dispensed into wells of a 96-well Serocluster PVC microplate (Corning Costar,
Tewksbury, MA) and the inoculated plates were incubated at 37°C for 24 h. After that,
the plates were rinsed twice in RO water to remove unattached cells and media
components. To stain the biofilms, 125 µL of 0.1 % crystal violet was added to each well
and allowed to incubate for 15 min. Crystal violet was then discarded, and the
microplates were rinsed four times with RO water and dried for 2 h. In order to quantify
the biofilms, 125 µL of 30% acetic acid were added to each well of the microtiter plates
and left for 15 mins. The solution was transferred to a CytoOne flat-bottom 96-well
microtiter plate (USA Scientific, Ocala, FL), and the amount of solubilized dye was
measured at 550 nm using 30% acetic acid as a blank and bacteria grown in the absence
of compounds served as the positive control. Experiments were repeated at least three
times with 10 replicates for each treatment.
4.3.3 Swimming, twitching, and swarming motility assays
The effect of furaneol on the swimming and swarming motility was determined
using a protocol of Ha et al.21,22, while the twitching motility assay was carried out as
described by Turnbull and Whitchurch.22,23 The assays were performed in M8 medium
(0.2% glucose, 0.5% casamino acid, and 1mM MgSO4) supplemented with 0.3% agar for
swimming, 0.8% for swarming, and 1% for twitching motility. The culture medium was
further amended with 0, 2, or 4 mg mL-1 of furaneol. Twitching motility was determined
by stab-inoculating the center of the plate with a sterile toothpick dipped in the overnight
culture of P. aeruginosa PAO1. Swarming motility was determined by spotting 2.5 µL of
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overnight culture in the center of a plate. Swimming motility was determined by stab
inoculating M8 agar with a toothpick without touching the bottom of the plate. All plates
were incubated at 37°C, and the diameter of colonies was measured after 24 h of growth.
4.3.4 Quantification of pyocyanin
Pyocyanin production was determined as described by Kern et al.22,24 Briefly, P.
aeruginosa was cultured at 37°C with shaking at 220 rpm for 24 h in KMA with and
without furaneol. After incubation, each 3-mL culture was mixed with 1.5 mL of
chloroform and vigorously vortexed for 30 s. After incubation for 10 min at room
temperature, the bottom organic layer was aspirated and clarified by spinning for 5 min at
6,000 g. The chloroform extracts were then acidified with 200 µL of 0.1 N HCl, and
their absorbance was measured at 520 nm. The absorbance values were multiplied by
17.072 to determine the concentration of pyocyanin in µg mL-1. Experiments were
repeated three times, with five replicates per treatment.
4.3.5 Determination of the exoprotease activity
In order to determine the effect of furaneol on protease production, bacterial
cultures were grown and treated with furaneol as described above for pyocyanin
production. Protease activity was determined using azocasein (Thermo Fisher) as a
described by Andrejko et al.25 One day old cultures were centrifuged at 12,000 g for 10
min at 4C, and 250 µL of the supernatant were mixed with equal volume of azocasein
(5 mg mL-1 in water) and incubated for 1 h at 37C. The reaction was stopped with 250
µL of 20% trichloroacetic acid and allowed to stand for 15 min to ensure complete
inactivation.26 The samples were then centrifuged again for 10 mins at 20,000 g, and
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750 µL of the supernatant were mixed with 375 µL of 0.5 M NaOH. The protease activity
was quantified by measuring absorbance at 366 nm.27 The experiment was repeated
twice, with five replicates per treatment.
4.3.6 Preparation of polymeric antimicrobial discs
A stock resin solution was prepared by combining and mixing thoroughly 2.00
grams of TTT (8.04 mmol, 24.12 mmol ene), 2.95 grams of PETMP (6.03 mmol, 24.12
mmol SH), and 495 mg Darocur 1173 (3.01 mmol, 10% w/w, 12.5 mol percent relative to
SH). The polymer matrix containing a combination of furaneol and p-anisaldehyde was
prepared using 100 mg furaneol (17.8% total resin mass), 125 mg p-anisaldehyde (21.4%
w/w), and 336 mg stock resin (60% w/w). Preliminary experiments indicated that the
addition of hydrophilic furaneol to thiol-ene networks accelerates the release of panisaldehyde. Therefore, to match the release profile of the combination matrix, the panisaldehyde-only polymer was prepared using 160 mg of p-anisaldehyde (28.6% w/w)
and 400 mg stock resin (31.4% w/w). Finally, the furaneol-only polymer network was
prepared using 100 mg of furaneol (17.8% w/w) and 462 mg of stock resin (82.2% w/w).
Aliquots (60, 70, or 80 μL ) of each material were dispensed onto glass slides separated
with 0.75-mm thick PTFE spacers and cured for 120 s with an Omnicure S1000-1B UV
light source (100 W mercury lamp, λmax = 365 nm, 320–500 nm filter) at an intensity of
200 mW cm-2. A similar approach was used to prepare from the stock resin inactive
control discs.
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4.3.7 Evaluation of the effect of polymeric antimicrobial discs on the production of
pyocyanin and exoprotease
Overnight bacterial cultures were diluted to 107 CFUs mL-1 in KMA or MHB
broth for the production of pyocyanin and exoprotease, respectively, and dispensed in 4
mL aliquots into culture tubes. Polymeric antimicrobial discs (60 mm3) containing
furaneol, p-anisaldehyde, or a combination of both compounds were placed in the
inoculated tubes, which were then incubated for 24 h at 37C with shaking at 220 rpm.
The amount of secreted pyocyanin and exoprotease activity was measured as described
above. Negative control included polymeric discs without bioactive compounds. All
treatments were replicated five times, and the entire experiment was repeated twice.
4.3.8 Biofilm assays
We used a modified procedure of Haney et al.28 to evaluate the ability of the
polymers containing furaneol and p-anisaldehyde to inhibit the establishment of surfaceattached biofilms. Briefly, MHB cultures of P. aeruginosa were adjusted to 107 CFUs
mL-1 and dispensed in 100-µL aliquots into wells of a 96-well Serocluster PVC
microplate (Corning Costar). Polymeric discs containing furaneol, p-anisaldehyde, or a
combination of both compounds were then aseptically placed into each microplate well.
Three different disc sizes (1.5, 1.75, and 2 mm3) were used in these experiments, and
discs without furaneol or p-anisaldehyde served as a vehicle control. The microplates
were incubated for 24 h at 37C, after which the plates were gently rinsed twice with RO
water, and allowed to dry overnight at room temperature to fix bacterial biofilms.29 The
dry biofilms were stained for 45 min with 125 µL of 0.1 % crystal violet, after which the
dye was discarded, and microplates were rinsed three times with RO water and dried for
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2 h. The retained dye was solubilized with 30% acetic acid and quantified by measuring
absorbance at 550 nm.
We also tested the ability of polymeric discs to eradicate mature P. aeruginosa
biofilms. Static biofilms were established by growing bacteria for 24 h at 37C in a
microplate prefilled with MHB. Following the incubation, culture liquid containing
planktonic cells was removed, and each well was gently rinsed and filled with 100 µL of
fresh culture medium. Antimicrobial polymeric discs were placed into microplate wells,
and the plates were incubated statically at 37C for 24 h and processed as described
above. The amount of eradicated biofilm was calculated relative to the amount of biofilm
grown in the presence of vehicle control. All experiments were repeated five times with
five replicates per treatment.
4.3.9 Confocal microscopy
Biofilms for microscopic observations were grown identically to the eradication
assay, except that the experiment was performed in Nunc MicroWell 96-well optical
bottom microplates (ThermoFisher). The established biofilms were exposed to
antimicrobial discs for 3 h at 37C, after which microplate wells were carefully rinsed
twice with sterile PBS and stained using a LIVE/DEAD bacterial viability kit (Thermo
Fisher).30 Briefly, 2 stocks of SYTO-9 and propidium iodide were dissolved in 5 mL of
sterile RO water, and 200 µL of the dye mixture were added to each microplate well and
incubated at room temperature in the dark for 45 min. The dye was then carefully
aspirated, and microplate wells were rinsed with sterile PBS and filled with 100 µL of
fresh MHB. The confocal microscopy was performed using a Zeiss 510 UV/META LSM
microscope (Zeiss, Oberkochen, Germany) with the excitation/emission maxima set to
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480/500 nm for green fluorescence, and 490/635 nm for red fluorescence. Images were
captured at 40 magnification, and three-dimensional images (z-stacks) of adhered
biofilms were captured and compiled using the Zen software (Zeiss).
4.4 Results and Discussion
The overall goal of this study was to improve the antimicrobial efficacy of panisaldehyde thiol-ene polymers against biofilms formed by P. aeruginosa. We
hypothesized that the release of the quorum-sensing inhibitors would trigger the
transition of bacteria from the recalcitrant surface-attached biofilm to a suspended
planktonic mode of growth, which would render them more susceptible to destruction by
p-anisaldehyde. Furthermore, we reasoned that the presence of QSIs would inhibit the
secretion of QS-mediated secretion of virulence factors. We started, therefore, by testing
p-anisaldehyde, EGCG, furaneol, and their combinations for their ability to inhibit the
formation of biofilms in P. aeruginosa. The results of this experiment revealed that panisaldehyde and EGCG alone had no significant effect on the biofilm formation (Fig.
4.1A). However, the combination of EGCG or furaneol with p-anisaldehyde, reduced the
amount of biofilm by 43% and 92%, respectively, compared to the non-treated control.
Also, there was no significant difference between the levels of biofilms produced in
cultures amended by only furaneol or a combination of furaneol and p-anisaldehyde. We
further confirmed that these compounds do not act synergistically against planktonic cells
(data not shown). In agreement with other studies, 16 we found that sub-inhibitory
concentrations of furaneol significantly (P < 0.05) decreased the swimming, swarming,
and twitching motility in P. aeruginosa (Fig. 4.1B). At the highest tested concentration,
furaneol reduced the flagella-mediated swimming by 54%, swarming motility by 80%,
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and the type IV pili-dependent twitching motility by 94%. Additionally, we found that 4
mg mL-1 of furaneol reduced the concentration of pyocyanin by approximately six-fold
compared to the untreated control (Fig. 4.1C). We also observed a modest effect in the
production of exoprotease, which dropped in cultures treated for 24 h with the highest
furaneol concentration by 26 Units (Fig. 4.1D).

Figure 4.1 The effect of p-anisaldehyde (pA), EGCG, furaneol, and their combinations on
the formation of static biofilms (A). Also shown is the effect of furaneol on the surface
motility (B), accumulation of pyocyanin (C), and exoprotease activity (D) in P.
aeruginosa PAO1.
The pyocyanin and protease data were analyzed by Tukey’s multiple comparisons HSD test (P < 0.05), while the surface motility and
biofilm data were analyzed by the Kruskal Wallis rank sum test, followed by the Dunn’s non-parametric test for multiple comparisons
(P < 0.05). Treatments that do not share letters are significantly different.

Although quorum sensing inhibitors act to repress the quorum sensing, the exact
modulatory effect on the pathogen can be complicated. For example, the application of
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sub-MIC concentrations of the antibiotic azithromycin, which acts as a quorum sensing
inhibitor in P. aeruginosa, resulted in high mortality in mice, which was likely triggered
by the bacterial switch from the chronic to acute mode of infection and induction of nonQS-dependent virulence determinants, such as the type III secretion system.31 Therefore,
it is important to combine quorum sensing inhibitors with effective antimicrobials to
lessen the chance of the activation of

Figure 4.2. The effect of polymeric antimicrobial discs containing p-anisaldehyde,
furaneol, and the combination of thereof on the production of pyocyanin (A), protease
activity (B), and formation of biofilms (C). Panel illustrates the capacity of varying size
polymeric discs to eradicate mature biofilms of P. aeruginosa (D).
Data represent mean ± standard deviation (SD) of five biological replicates. Bars with different letters or asterisks indicate significant
differences as determined by the Tukey’s HSD test (P < 0.05).
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non-quorum sensing-dependent virulence traits and guarantee the complete eradication of
the pathogen. We aimed to achieve this goal by generating an antimicrobial polymeric
network, which was produced using the thiol-ene photopolymerization in the presence of
furaneol and p-anisaldehyde, which acted, respectively, as a quorum sensing inhibitor and
an antimicrobial agent. The exposure of P. aeruginosa PAO1 to polymeric discs
containing furaneol or the furaneol/ p-anisaldehyde combination strongly repressed the
production of pyocyanin (Fig. 4.2A) and reduced the exoprotease activity significantly by
8 and 24 Units, respectively (Fig. 4.2B). We proceeded to measure the ability of the
furaneol- and p-anisaldehyde-containing polymers to prevent the establishment and
eradicate biofilms formed by P. aeruginosa. The 24-h exposure to discs containing both
compounds effectively prevented bacteria from colonizing the solid surface (Fig. 4.2C)
and completely abolished the established biofilms (Fig. 4.2D). This effect was not
achieved by treating cultures with the corresponding small molecules.
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A)

B)

C)

D)

Figure 4.3. Changes in the viability of mature P. aeruginosa biofilms after 3 h of
exposure to polymeric antimicrobial discs containing a combination of furaneol and panisaldehyde (A), p-anisaldehyde (B), furaneol (C), or no antimicrobials (vehicle control)
(D).
Viable cells appear green, while dead cells are stained red. The biofilms were stained using the LIVE/DEAD Bacterial Viability Kit
and imaged with a Zeiss LSM microscope at 40x magnification. Three-dimensional images (z-stacks) of adhered biofilms were
captured and compiled using the Zen software (Zeiss).

The confocal microscopy revealed that the exposure to the furaneol/p-anisaldehydecontaining polymer for only 3 hours significantly impacted the appearance of P.
aeruginosa biofilms. The LIVE/DEAD staining showed that nearly all the cells in the
combination treatment were dead, while considerably higher levels of live bacteria were
present in the furaneol and control treatments (Figure 4.3). The presence of both furaneol
and p-anisaldehyde also changed the appearance of biofilms rendering them less compact
and reducing the presence of mushroom-shaped structures. Interestingly, although
furaneol and the combination of furaneol with p-anisaldehyde performed equally well at
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eradicating biofilms (Fig. 4.1A), the polymeric disks containing both compounds
outperformed their furaneol-only counterparts (Fig. 4.2D). The effect was also evident
during microscopy observations, where biofilms exposed to the furaneol/p-anisaldehyde
polymer clearly showed a higher proportion of dead cells.
In conclusion, we demonstrated that plant-derived bioactive compounds could be
combined to target quorum sensing regulation and biofilms in pathogenic bacteria. In
particular, the treatment of P. aeruginosa with a mix of furaneol and p-anisaldehyde
effectively disrupted the secretion of QS-regulated virulence factors and the formation of
static biofilms. Both compounds also can be incorporated into antimicrobial thiol-ene
polymeric networks, which enables high loading, efficient “encapsulation,” solvent-free
processing, and sustained release profiles. Our results will facilitate the development of
polymeric systems capable of dual phytochemical delivery and controlling microbial
growth without promoting antibiotic resistance.
4.5 References
(1)

Smith, K. M.; Bu, Y.; Suga, H. Induction and inhibition of Pseudomonas
aeruginosa quorum sensing by synthetic autoinducer analogs. Chem. Biol. 2003,
10 (1), 81–89.

(2)

El-Shaer, S.; Shaaban, M.; Barwa, R.; Hassan, R. Control of quorum sensing and
virulence factors of Pseudomonas aeruginosa using phenylalanine arginyl bnaphthylamide. J. Med. Microbiol. 2016, 65, 1194–1204.

(3)

Moradali, M. F.; Ghods, S.; Rehm, B. H. A. Pseudomonas aeruginosa lifestyle: a
paradigm for adaptation, survival, and persistence. Front. Cell. Infect. Microbiol.
2017, 7, 1–29.
109

(4)

Brackman, G.; Coenye, T. Quorum sensing inhibitors as anti-biofilm agents. Curr.
Pharm. Des. 2014, 21 (1), 5–11.

(5)

Siryaporn, A.; Kuchma, S. L.; O’Toole, G. A.; Gitai, Z. Surface attachment
induces Pseudomonas aeruginosa virulence. Proc. Natl. Acad. Sci. 2014, 111 (47),
16860–16865.

(6)

Burrows, L. L. Pseudomonas aeruginosa twitching motility: type iv pili in action.
Annu. Rev. Microbiol. 2012, 66 (1), 493–520.

(7)

Daniels, R.; Vanderleyden, J.; Michiels, J. Quorum sensing and swarming
migration in bacteria. FEMS Microbiol. Rev. 2004, 28 (3), 261–289.

(8)

Asfour, H. Z. Antiquorum sensing natural compounds. J. Microsc. Ultrastruct.
2017, No. 122, 1–12.

(9)

Chatterjee, M.; Anju, C. P.; Biswas, L.; Anil Kumar, V.; Gopi Mohan, C.; Biswas,
R. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic
options. Int. J. Med. Microbiol. 2016, 306 (1), 48–58.

(10)

Lin, J.; Cheng, J.; Wang, Y.; Shen, X. The Pseudomonas quinolone signal (pqs):
not just for quorum sensing anymore. Front. Cell. Infect. Microbiol. 2018, 8 (230),
1–9.

(11)

Rutherford, S. T.; Bassler, B. L.; Delany, I.; Rappuoli, R.; Seib, K. L.; Ben-tekaya,
H.; Gorvel, J.; Ruhe, C. Bacterial Quorum Sensing : Its role in virulence and
possibilities for its control. Cold Spring Harb Perspect Med 2014, 2, 1–26.

(12)

de Kievit, T. R. Quorum sensing in Pseudomonas Aeruginosa biofilms. Environ.
Microbiol. 2009, 11 (2), 279–288.

(13)

LaSarre, B.; Federle, M. J. Exploiting quorum sensing to confuse bacterial
110

pathogens. Microbiol. Mol. Biol. Rev. 2013, 77 (1), 73–111 DOI:
10.1128/MMBR.00046-12.
(14)

Reichelt, J. L.; Borowitzka, M. A. Antimicrobial activity from marine algae:
results of a large-scale screening programme. Hydrobiologia 1984, 116–117 (1),
158–168.

(15)

Manefield, M.; Rasmussen, T. B.; Henzter, M.; Andersen, J. B.; Steinberg, P.;
Kjelleberg, S.; Givskov, M. Halogenated furanones inhibit quorum sensing
through accelerated luxr turnover. Microbiology 2002, 148 (4), 1119–1127.

(16)

Choi, S.-C.; Zhang, C.; Moon, S.; Oh, Y.-S. Inhibitory effects of 4-hydroxy-2,5dimethyl-3(2h)-furanone (hdmf) on acyl-homoserine lactone-mediated virulence
factor production and biofilm formation in Pseudomonas aeruginosa PAO1. J.
Microbiol. 2014, 52 (9), 734–742.

(17)

Amato, D. V; Amato, D. N.; Blancett, L. T.; Mavrodi, O. V; Martin, W. B.;
Swilley, S. N.; Sandoz, M. J.; Shearer, G.; Mavrodi, D. V; Patton, D. L. A biobased pro-antimicrobial polymer network via degradable acetal linkages. Acta
Biomater. 2018, 67, 196–205.

(18)

Amato, D. N.; Amato, D. V.; Mavrodi, O. V.; Braasch, D. A.; Walley, S. E.;
Douglas, J. R.; Mavrodi, D. V.; Patton, D. L. Destruction of opportunistic
pathogens via polymer nanoparticle-mediated release of plant-based antimicrobial
payloads. Adv. Healthc. Mater. 2016, 5 (9), 1094–1103.

(19)

King, E. O.; Ward, M. K.; Raney, D. E. Two Simple media for the demonstration
of pyocyanin and fluorescin. J. Lab. Clin. Med. 1954, 44 (2), 301–307.

(20)

O’Toole, G. A. Microtiter dish biofilm formation assay. J. Vis. Exp. 2011, 47, 1–2.
111

(21)

Ha, D.-G.; Kuchma, S. L.; O’Toole, G. A. Plate-Based Assay for swarming
motility in Pseudomonas aeruginosa. In Pseudomonas methods and protocols;
2014; pp 67–72.

(22)

Filloux, A.; Ramos, J.-L. Pseudomonas Methods and Protocols; Filloux, A.,
Ramos, J.-L., Eds.; Methods in molecular biology; Springer new york: new york,
NY, 2014; Vol. 1149.

(23)

Turnbull, L.; Whitchurch, C. B. Motility assay: twitching motility. In
Pseudomonas methods and protocols; Springer New York: New York, NY, 2014;
pp 73–86.

(24)

Kern, S. E.; Newman, D. K. Measurement of phenazines in bacterial cultures. In
Pseudomonas methods and protocols; Springer New York: New York, NY, 2014;
pp 303–310.

(25)

Andrejko, M.; Zdybicka-Barabas, A.; Janczarek, M. Three Pseudomonas
aeruginosa strains with different protease profiles. Acta Biochem. Pol. 2013, 60,
83–90.

(26)

Schmidtchen, A.; Wolff, H.; Hansson, C. Differential proteinase expression by
Pseudomonas aeruginosa derived from chronic leg ulcers. Acta Derm Venereol
2001, 81, 406–409.

(27)

Chessa, J.-P.; Petrescu, I.; Bentahir, M.; Van Beeumen, J.; Gerday, C. Purification,
physico-chemical characterization and sequence of a heat labile alkaline
metalloprotease isolated from a psychrophilic Pseudomonas species. Biochim.
Biophys. Acta - Protein Struct. Mol. Enzymol. 2000, 1479 (1–2), 265–274.

(28)

Haney, E. F.; Trimble, M. J.; Cheng, J. T.; Vallé, Q.; Hancock, R. E. W. Critical
112

assessment of methods to quantify biofilm growth and evaluate antibiofilm activity
of host defence peptides. Biomolecules 2018, 8 (29), 1–22.
(29)

Richter, A. M.; Fazli, M.; Schmid, N.; Shilling, R.; Suppiger, A.; Givskov, M.;
Eberl, L.; Tolker-Nielsen, T. Key players and individualists of cyclic-di-gmp
signaling in Burkholderia cenocepacia. Front. Microbiol. 2019, 9 (3386), 1–15.

(30)

Beaudoin, T.; Kennedy, S.; Yau, Y.; Waters, V. Visualizing the effects of sputum
on biofilm development using a chambered coverglass model. J. Vis. Exp. 2016,
118, 1–6.

(31)

Skindersoe, M. E.; Alhede, M.; Phipps, R.; Yang, L.; Jensen, P. O.; Rasmussen, T.
B.; Bjarnsholt, T.; Tolker-Nielsen, T.; Høiby, N.; Givskov, M. Effects of
antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents
Chemother. 2008, 52 (10), 3648–3663.

113

– CONCLUSIONS
Essential oils (EOs) are extracts of aromatic and medicinal plants that are
recognized by the American Food and Drug Administration (FDA) as Generally
Recognized as Safe (GRAS) substances and used in alternative medicine, agriculture,
food, and cosmetic industries. The EOs contain dozens of chemically-diverse
constituents, many of which possess antimicrobial properties and represent an attractive
alternative to conventional antibiotics due to the ability to kill microorganisms without
promoting resistance.1,2,3 However, their broader use in the control of microorganisms is
restricted by the low solubility, volatility, and lower activity compared to conventional
antibiotics. In addition, many details of the mechanism of action and synergistic
antimicrobial effects of individual EO constituents remain poorly understood.4 The
overarching aim of my work involved addressing these issues by studying molecular
interactions between antimicrobial plant aldehydes and the opportunistic human pathogen
Pseudomonas aeruginosa.
We tackled the chemical instability of EO-derived phytoaldehydes by
incorporating them into thioether acetal polymer networks called PANDAs. We also
broadened the antimicrobial activity of PANDAs by synthesizing them with
synergistically interacting combinations of plant metabolites. In the first part of my
project, we produced a new thiol-ene polymer using the synergistically interacting
combination of p-bromobenzaldehyde and p-anisaldehyde. That approach significantly
improved the antimicrobial activity of the polymer material killed and exhibited
negligible toxicity against mammalian tissue culture cells. We then probed cellular
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effects the p-anisaldehyde and demonstrated that the inactivation of the MexAB-OprM
multidrug efflux pump sensitizes P. aeruginosa to the action of p-anisaldehyde.
We built upon these findings by performing a transposon screen of cellular
pathways targeted by p-anisaldehyde in P. aeruginosa. We also demonstrated that the
putative efflux pump inhibitor epigallocatechin gallate (EGCG) interacts synergistically
with p-anisaldehyde and significantly reduces its minimal inhibitory concentration
against P. aeruginosa. We went further to determine the effects of p-anisaldehyde,
EGCG, and their combination on the transcriptome of P. aeruginosa using RNA-seq. Our
results suggested that p-anisaldehyde disrupts the envelope of bacterial cells and then
accumulates intracellularly, causing their misfolding and aggregation of proteins. In
contrast, EGCG likely acts by generating oxidative stress, which contributes to the ability
to complement and potentiate the antimicrobial action of p-anisaldehyde. The synergistic
antimicrobial interaction between the two compounds is further enhanced by the capacity
of EGCG to reverse the upregulation of many genes by p-anisaldehyde, including those
encoding various transporters and key RND efflux pumps. This part of my project
highlighted the important microbial genes and associated pathways involved in response
to plant-derived phenylpropanoid compounds. Additionally, by studying the interaction
of p-anisaldehyde and EGCG, we characterized some molecular mechanisms governing
the synergistic effects of individual constituents within essential oils.
Finally, we broadened the antimicrobial potential of the thiol-ene polymer
platform by incorporating a combination of p-anisaldehyde and furaneol, which is a
natural plant-derived inhibitor of quorum sensing. The treatment with furaneol/panisaldehyde-containing polymeric discs strongly repressed the production of pyocyanin,
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reduced the exoprotease activity, and effectively eradicated established P. aeruginosa
biofilms. Our results suggest that furaneol triggers the dispersion of biofilms, which
render the pathogen more vulnerable to the antimicrobial action of p-anisaldehyde. Our
results will facilitate the development of polymeric systems capable of dual
phytochemical delivery and controlling microbial growth without promoting antibiotic
resistance. Such materials enable the high loading, efficient encapsulation, and sustained
release of hydrophobic and volatile phytochemicals and could be used as antimicrobial
wound dressings, sprays, surface coatings, and packaging materials.
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Figure A.1 RT-FTIR polymerization monitoring of pCinA-PETMP resin upon exposure to
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Figure A.2 RT-FTIR polymerization monitoring of 40:60 pBA:pAA – PETMP coPANDA resin upon exposure to UV light.
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Figure A.3 Dynamic mechanical analysis of 40:60 pBA:pAA co-PANDA disk.
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Figure A.4 The results of screening of mutants for hypersensitivity to sub-inhibitory
concentrations (0.6 x MIC) of pA and pB.
The shaded part of the graph indicates sensitive mutants (factor of inhibition (F1) values ≥ 9) that were selected for further analysis. The
mexA (#50) and oprF (#70) mutants are highlighted with dashed lines.
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Table A.1 Oligonucleotide primers and qPCR probes used in this study.
Primer or probe

Sequence

Referencea

TET-1FP-3

5’-GCATCTCGGGCACGTTGGGTCCT-3’

Lucigen

TET-1RP-4

5’-CGAGGATGACGATGAGCGCATTGTTAG-3’

Lucigen

rpoD-F

5'-GGGCTGTCTCGAATACGTTGA-3'

Quale et al., 2006

rpoD-R

5'-ACCTGCCGGAGGATATTTCC-3'

Quale et al., 2006

rpoD-P

5'-[FAM]-TGCGGATGATGTCTTCCACCTGTTCC-[TAM]-3’ Quale et al., 2006

mexA-F

5'-AACCCGAACAACGAGCTG-3'

Quale et al., 2006

mexA-R

5'-ATGGCCTTCTGCTTGACG-3'

Quale et al., 2006

mexA-P

5’-[FAM]-CATGTTCGTTCACGCGCAGTTG-[TAM]-3’

Quale et al., 2006

mexC-F

5'-GGAAGAGCGACAGGAGGC-3'

Quale et al., 2006

mexC-R

5'-CTGCACCGTCAGGCCCTC-3'

Quale et al., 2006

mexC-P

5’-[FAM]-CCGAAATGGTGTTGCCGGTG-[TAM]-3’

Quale et al., 2006

mexE-F

5'-TACTGGTCCTGAGCGCCT-3'

Quale et al., 2006

mexE-R

5'-TCAGCGGTTGTTCGATGA-3'

Quale et al., 2006

mexE-P

5’-[FAM]-CGGAAACCACCCAAGGCATG-[TAM]-3’

Quale et al., 2006

mexX-F

5'-GGCTTGGTGGAAGACGTG-3'

Quale et al., 2006

mexX-R

5'-GGCTGATGATCCAGTCGC-3'

Quale et al., 2006

mexX-P

5’-[FAM]-CCGACACCCTGCAGGGCC-[TAM]-3’

Quale et al., 2006

Table A.1 (Continued)

a

Primer or probe

Sequence

Referencea

mexK-R

5'-CAGGCGGTCGGCATAGTC-3'

This study

mexK-P

5’-[FAM]-CAAGGGCTTCGACTACGCGGTG-[BHQ1]-3’

This study

muxB-F

5'-ATGGTGGCGATCCTGCTC-3'

This study

muxB-R

5'-GATGGTCGGGTAGTCCACTTC-3'

This study

muxB-P

5’-[FAM]-GATCGCCTACCGCTTCCTGCCG-[BHQ1]-3’

This study

PA1541-F

5'-TGATCGGCCTGTCCTATTTCTTC-3'

This study

PA1541-R

5'-GTGATCAGGACGATGCCAATG-3'

This study

PA1541-P

5’-[FAM]-CCCTGGCGGTCAAGCGTGTC-[BHQ1]-3’

This study

Oligonucleotide primers and probes targeting rpoD, mexA, mexC, mexE, and mexX genes were from the study by Quale et al.42

